[S02DA03, antipyrine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Antipyrine.]
[B01AD01, streptokinase, The therapeutic efficacy of Streptokinase can be decreased when used in combination with Cephalexin.]
[J01GA01, streptomycin, Cephalexin may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Cephalexin may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Cephalexin may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Cephalexin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The metabolism of Cephalexin can be decreased when combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The metabolism of Cephalexin can be increased when combined with Sulfinpyrazone.]
[M01AB02, sulindac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Sulindac.]
[M01AX04, apazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Azapropazone.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Cephalexin.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Cephalexin.]
[N05CD07, temazepam, Cephalexin may decrease the excretion rate of Temazepam which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Cephalexin.]
[R03CC03, terbutaline, Cephalexin may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Cephalexin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The metabolism of Cephalexin can be increased when combined with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Tetracaine.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Cephalexin.]
[J01DI02, ceftaroline fosamil, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Ceftaroline fosamil.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Cephalexin.]
[P02CA02, thiabendazole, Cephalexin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Cephalexin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Cephalexin.]
[G04BE06, moxisylyte, Cephalexin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Cephalexin may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Cephalexin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.]
[S01ED01, timolol, Cephalexin may decrease the excretion rate of Timolol which could result in a higher serum level.]
[P01AB02, tinidazole, Cephalexin may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Cephalexin may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Cephalexin may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Cephalexin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Cephalexin.]
[N02AX02, tramadol, Cephalexin may decrease the excretion rate of Tramadol which could result in a higher serum level.]
[S01BA05, triamcinolone, The metabolism of Cephalexin can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cephalexin.]
[N05CD05, triazolam, Cephalexin may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Cephalexin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Cephalexin.]
[R03BA07, mometasone, The metabolism of Cephalexin can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Cephalexin may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[J01EA01, trimethoprim, Cephalexin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[J01FA08, troleandomycin, The metabolism of Cephalexin can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Cephalexin.]
[L01FX04, ipilimumab, Cephalexin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Cephalexin.]
[R02AA14, oxyquinoline, Cephalexin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Cephalexin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Cephalexin can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Cephalexin can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Cephalexin can be decreased when combined with Rilpivirine.]
[B01AD04, urokinase, The therapeutic efficacy of Urokinase can be decreased when used in combination with Cephalexin.]
[S01AA28, vancomycin, Cephalexin may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Cephalexin may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Cephalexin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The metabolism of Cephalexin can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Cephalexin can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Cephalexin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Cephalexin.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Cephalexin.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Cephalexin.]
[B03BA01, vitamin B12, Cephalexin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.]
[A11HA03, vitamin E, The metabolism of Cephalexin can be increased when combined with Vitamin E.]
[B01AA03, warfarin, Cephalexin may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The excretion of Cephalexin can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Cephalexin.]
[J05AE02, indinavir, The metabolism of Cephalexin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Cephalexin.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Cephalexin.]
[M05BA05, tiludronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Tiludronic acid.]
[B06AC02, icatibant, Cephalexin may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Cephalexin.]
[B01AE01, desirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin.]
[R03DC01, zafirlukast, The metabolism of Cephalexin can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Cephalexin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Ibandronate.]
[N05AE04, ziprasidone, The metabolism of Cephalexin can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Cephalexin may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The excretion of Cephalexin can be decreased when combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Cephalexin.]
[G04BD07, tolterodine, Cephalexin may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Cephalexin.]
[J02AC03, voriconazole, The metabolism of Cephalexin can be decreased when combined with Voriconazole.]
[M01CB03, auranofin, Cephalexin may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Cephalexin.]
[R07AX02, ivacaftor, The metabolism of Cephalexin can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Cephalexin can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Cephalexin may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Cephalexin may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Cephalexin may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Cephalexin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Cephalexin may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Bacitracin.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Cephalexin.]
[M03BX01, baclofen, Cephalexin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[S01AA13, fusidic acid, The metabolism of Cephalexin can be decreased when combined with Fusidic acid.]
[M05BA03, pamidronic acid, The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Cephalexin.]
[A08AA11, lorcaserin, Cephalexin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Cephalexin may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[V03AX03, cobicistat, The metabolism of Cephalexin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Cephalexin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Cephalexin can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Cephalexin.]
[L04AA31, teriflunomide, The excretion of Cephalexin can be decreased when combined with Teriflunomide.]
[B01AX01, defibrotide, The therapeutic efficacy of Defibrotide can be decreased when used in combination with Cephalexin.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Cephalexin.]
[N05CA04, barbital, The metabolism of Cephalexin can be increased when combined with Barbital.]
[D02BA02, octinoxate, Cephalexin may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Cephalexin can be decreased when combined with Nelfinavir.]
[N04BD02, rasagiline, Cephalexin may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[N03AX22, perampanel, The metabolism of Cephalexin can be increased when combined with Perampanel.]
[V09IX04, fluorodeoxyglucose F18, Cephalexin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[H01CB05, pasireotide, The metabolism of Cephalexin can be decreased when combined with Pasireotide.]
[V08CA11, gadofosveset, Cephalexin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Cephalexin.]
[B01AF02, apixaban, The therapeutic efficacy of Apixaban can be decreased when used in combination with Cephalexin.]
[A16AX08, teduglutide, Cephalexin may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Cephalexin.]
[A10BH04, alogliptin, Cephalexin may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Cephalexin can be increased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Cephalexin.]
[N02BA10, benorilate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Benorilate.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Benzocaine.]
[J02AX04, caspofungin, The excretion of Cephalexin can be decreased when combined with Caspofungin.]
[L03AA12, ancestim, Cephalexin may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Cephalexin.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Cephalexin.]
[N04AC01, benztropine, Cephalexin may decrease the excretion rate of Benzatropine which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Cephalexin can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Benzydamine.]
[L01EE01, trametinib, Cephalexin may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Cephalexin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Cephalexin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[J05AJ03, dolutegravir, The excretion of Cephalexin can be decreased when combined with Dolutegravir.]
[A10BJ03, lixisenatide, Cephalexin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Cephalexin.]
[C02KX04, macitentan, Cephalexin may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Cephalexin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Cephalexin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The metabolism of Cephalexin can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Cephalexin can be decreased when combined with Simeprevir.]
[V03AE05, sucroferric oxyhydroxide, The therapeutic efficacy of Cephalexin can be decreased when used in combination with Iron sucrose.]
[J05AP08, sofosbuvir, Cephalexin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Cephalexin may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Cephalexin.]
[A16AA07, metreleptin, The metabolism of Cephalexin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Cephalexin can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Cephalexin can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Cephalexin can be increased when combined with Betamethasone.]
[B01AE03, argatroban, The therapeutic efficacy of Argatroban can be decreased when used in combination with Cephalexin.]
[V03AB34, fomepizole, Cephalexin may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[L04AC11, siltuximab, The metabolism of Cephalexin can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Cephalexin.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Cephalexin.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Cephalexin.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Cephalexin.]
[N07XX08, tafamidis, The excretion of Cephalexin can be decreased when combined with Tafamidis.]
[V08AA01, diatrizoic acid, Cephalexin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[V08AA04, iothalamic acid, Cephalexin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Cephalexin.]
[J01XA05, oritavancin, The metabolism of Cephalexin can be increased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Dihydrostreptomycin.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Cephalexin.]
[S03AA06, gentamicin, Cephalexin may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Cephalexin.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Cephalexin is combined with Dicoumarol.]
[B01AF03, edoxaban, Cephalexin may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The metabolism of Cephalexin can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Cephalexin can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Cephalexin.]
[L01EX08, lenvatinib, The excretion of Cephalexin can be decreased when combined with Lenvatinib.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Cephalexin.]
[N02BE01, acetaminophen, The metabolism of Cephalexin can be increased when combined with Acetaminophen.]
[L01DC01, bleomycin, Cephalexin may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Cephalexin is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Adefovir dipivoxil.]
[J05AP06, asunaprevir, The metabolism of Cephalexin can be increased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Cephalexin.]
[B01AC25, cangrelor, The therapeutic efficacy of Cangrelor can be decreased when used in combination with Cephalexin.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Cephalexin.]
[M02AA25, aceclofenac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, The excretion of Cephalexin can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Cephalexin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Cephalexin.]
[J02AC05, isavuconazole, The metabolism of Cephalexin can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Cephalexin.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Cephalexin.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Cephalexin.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Cephalexin.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Cephalexin.]
[M04AB05, lesinurad, The metabolism of Cephalexin can be increased when combined with Lesinurad.]
[N05CA05, aprobarbital, The metabolism of Cephalexin can be increased when combined with Aprobarbital.]
[M01AE16, alminoprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Alminoprofen.]
[N03AX23, brivaracetam, Cephalexin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Cephalexin.]
[N05BA08, bromazepam, Cephalexin may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Cephalexin may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Cephalexin.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Cephalexin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Bupivacaine.]
[N07BC01, buprenorphine, The metabolism of Cephalexin can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, Cephalexin may decrease the excretion rate of Buspirone which could result in a higher serum level.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Cephalexin.]
[L01XX27, arsenic trioxide, Cephalexin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Cephalexin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[L01XK03, rucaparib, The metabolism of Cephalexin can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Cephalexin can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Cephalexin can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Balsalazide.]
[A06AH05, naldemedine, Cephalexin may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Cephalexin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Cephalexin may decrease the excretion rate of Pregabalin which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Cephalexin can be increased when combined with Calcitriol.]
[P01CA02, benznidazole, Cephalexin may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The excretion of Cephalexin can be decreased when combined with Linezolid.]
[J05AF06, abacavir, Cephalexin may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Cephalexin can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, Cephalexin may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Cephalexin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Cephalexin can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Cephalexin.]
[L04AC14, sarilumab, The metabolism of Cephalexin can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, Cephalexin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The therapeutic efficacy of Betrixaban can be decreased when used in combination with Cephalexin.]
[D01AC10, bifonazole, The metabolism of Cephalexin can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, Cephalexin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Cephalexin.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Cephalexin.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Cephalexin.]
[L01EF03, abemaciclib, The excretion of Abemaciclib can be decreased when combined with Cephalexin.]
[C07AB07, bisoprolol, Cephalexin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Cephalexin can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefprozil.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Cephalexin can be increased when combined with Budesonide.]
[M01AB07, bumadizone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Cephalexin.]
[J05AX18, letermovir, The excretion of Cephalexin can be decreased when combined with Letermovir.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Cephalexin may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Cephalexin.]
[L02BB05, apalutamide, The metabolism of Cephalexin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Cephalexin can be increased when combined with Carbamazepine.]
[J01CA03, carbenicillin, The excretion of Cephalexin can be decreased when combined with Carbenicillin.]
[B02BX09, fostamatinib, The metabolism of Cephalexin can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Cephalexin can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The excretion of Cephalexin can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Cephalexin.]
[J01DE01, cefepime, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefepime.]
[J01DD10, cefetamet, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefetamet.]
[J01DD09, cefodizime, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefodizime.]
[J01DC11, ceforanide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Ceforanide.]
[J01DD13, cefpodoxime, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefpodoxime.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Cephalexin.]
[J01GB14, plazomicin, Cephalexin may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[L01XX62, ivosidenib, The metabolism of Cephalexin can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The excretion of Cephalexin can be decreased when combined with Tafenoquine.]
[A16AX14, migalastat, Cephalexin may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Cephalexin can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Cephalexin can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Cephalexin.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Cephalexin.]
[S01GX12, cetirizine, Cephalexin may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Cephalexin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Lornoxicam.]
[N07XX15, inotersen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Inotersen.]
[L01ED05, lorlatinib, The metabolism of Cephalexin can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Cephalexin can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Cephalexin may decrease the excretion rate of Carmustine which could result in a higher serum level.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Cephalexin.]
[L01XJ03, glasdegib, The excretion of Cephalexin can be decreased when combined with Glasdegib.]
[A06AX05, prucalopride, Cephalexin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, Cephalexin may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[P02BX04, triclabendazole, The metabolism of Cephalexin can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Cephalexin can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Cephalexin.]
[J01FA09, clarithromycin, The metabolism of Cephalexin can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Cephalexin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Cephalexin.]
[N05BA09, clobazam, The metabolism of Cephalexin can be increased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Cephalexin can be increased when combined with Cloprednol.]
[L04AB01, etanercept, The metabolism of Cephalexin can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Cephalexin can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Cephalexin.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Cephalexin.]
[J01DB05, cefadroxil, The excretion of Cephalexin can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Cephalexin can be decreased when combined with Cefamandole.]
[J01DB07, cefatrizine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefatrizine.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Cephalexin.]
[J01DC09, cefmetazole, The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Cephalexin.]
[J01DC06, cefonicid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefonicid.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Cephalexin.]
[J01DD12, cefoperazone, The excretion of Cephalexin can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Cephalexin can be decreased when combined with Cefotaxime.]
[J01DC05, cefotetan, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefotetan.]
[J01DC07, cefotiam, The excretion of Cephalexin can be decreased when combined with Cefotiam.]
[J01DC01, cefoxitin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefoxitin.]
[J01DD03, cefsulodin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefsulodin.]
[J01DD02, ceftazidime, The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Cephalexin.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Cephalexin.]
[J01DD04, ceftriaxone, The excretion of Cephalexin can be decreased when combined with Ceftriaxone.]
[S01AA27, cefuroxime, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefuroxime.]
[L01EJ02, fedratinib, The excretion of Cephalexin can be decreased when combined with Fedratinib.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Cephalexin.]
[N07XX11, pitolisant, The serum concentration of Cephalexin can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Cephalexin.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Cephalexin.]
[N04CX01, istradefylline, The excretion of Cephalexin can be decreased when combined with Istradefylline.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Cephalexin may decrease the excretion rate of Daptomycin which could result in a higher serum level.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Cephalexin.]
[J01DB03, cephalothin, The excretion of Cephalexin can be decreased when combined with Cefalotin.]
[J01DB08, cephapirin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefapirin.]
[J01DB09, cephradine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Cephalexin can be increased when combined with Deflazacort.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Cephalexin.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Cephalexin.]
[N03AX25, cenobamate, The serum concentration of Cephalexin can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Givosiran.]
[M09AX08, golodirsen, Cephalexin may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Cephalexin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Cephalexin.]
[J05AB16, remdesivir, The metabolism of Cephalexin can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Cephalexin can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Cephalexin can be decreased when combined with Amprenavir.]
[R02AA03, dichlorobenzyl alcohol, Cephalexin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Cephalexin may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Cephalexin.]
[L01XF03, bexarotene, The metabolism of Cephalexin can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Cephalexin can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Cephalexin.]
[J01FA13, dirithromycin, The metabolism of Cephalexin can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Cephalexin can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Cephalexin.]
[L01EX17, capmatinib, The excretion of Cephalexin can be decreased when combined with Capmatinib.]
[D07XB03, fluprednidene, The metabolism of Cephalexin can be increased when combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Droxicam.]
[L01EX19, ripretinib, The excretion of Cephalexin can be decreased when combined with Ripretinib.]
[V08CA05, mangafodipir, Cephalexin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The excretion of Cephalexin can be decreased when combined with Selpercatinib.]
[B01AE02, lepirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin.]
[M02AA27, dexketoprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Dexketoprofen.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Dyclonine.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Cephalexin.]
[M09AX10, risdiplam, The serum concentration of Cephalexin can be increased when it is combined with Risdiplam.]
[L04AC19, satralizumab, The serum concentration of Cephalexin can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Cephalexin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EX23, pralsetinib, The metabolism of Cephalexin can be increased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, The metabolism of Cephalexin can be increased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Cephalexin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Cephalexin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Ethenzamide.]
[N02BA03, choline salicylate, Cephalexin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[M01AB08, etodolac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Cephalexin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Cephalexin can be decreased when combined with Lonafarnib.]
[M01AX25, chondroitin sulfates, Cephalexin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[J05AJ04, cabotegravir, The excretion of Cephalexin can be decreased when combined with Cabotegravir.]
[P03AX07, abametapir, The serum concentration of Cephalexin can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, The excretion of Cephalexin can be decreased when combined with Trilaciclib.]
[N03AX10, felbamate, The metabolism of Cephalexin can be increased when combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Fenbufen.]
[C01CA19, fenoldopam, Cephalexin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[B03AB02, iron sucrose, The therapeutic efficacy of Cephalexin can be decreased when used in combination with Iron sucrose.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Cephalexin.]
[R03BA03, flunisolide, The metabolism of Cephalexin can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Cephalexin can be increased when combined with Fluocinolone acetonide.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Cephalexin.]
[N02BG07, flupirtine, Cephalexin may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[A02BA01, cimetidine, The excretion of Cephalexin can be decreased when combined with Cimetidine.]
[V08CA04, gadoteridol, Cephalexin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[J01MB06, cinoxacin, The excretion of Cephalexin can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Cephalexin can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Cephalexin.]
[S03AA07, ciprofloxacin, The metabolism of Cephalexin can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Cephalexin may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The metabolism of Cephalexin can be decreased when combined with Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The excretion of Cephalexin can be decreased when combined with Fexinidazole.]
[V09AB03, ioflupane I-123, Cephalexin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Cephalexin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Cephalexin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[L04AA59, avacopan, The metabolism of Cephalexin can be decreased when combined with Avacopan.]
[M01AG01, mefenamic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Mefenamic acid.]
[N06AX25, St. John's wort extract, The metabolism of Cephalexin can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Cephalexin can be decreased when combined with Asciminib.]
[J04BA01, clofazimine, The metabolism of Cephalexin can be decreased when combined with Clofazimine.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cephalexin.]
[C10AB01, clofibrate, The metabolism of Cephalexin can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Cephalexin can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The metabolism of Cephalexin can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Cephalexin.]
[N03AE01, clonazepam, Cephalexin may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Cephalexin.]
[C01EB24, mavacamten, The serum concentration of Cephalexin can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Cephalexin.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, The metabolism of Cephalexin can be decreased when combined with Clozapine.]
[J01GB12, arbekacin, Cephalexin may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Cephalexin can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Cephalexin can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Proquazone.]
[R05DA04, codeine, The excretion of Cephalexin can be decreased when combined with Codeine.]
[M04AC01, colchicine, Cephalexin may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Cephalexin may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefpirome.]
[A04AA03, tropisetron, Cephalexin may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Cephalexin may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Imidazole salicylate.]
[J01FA15, telithromycin, The metabolism of Cephalexin can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Indobufen.]
[J05AB14, valganciclovir, Cephalexin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[J05AF09, emtricitabine, The excretion of Emtricitabine can be decreased when combined with Cephalexin.]
[C05BB03, invert sugar, Cephalexin may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Cephalexin may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Cephalexin may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Cephalexin may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Cephalexin may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Valdecoxib.]
[N02CC05, almotriptan, Cephalexin may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Cephalexin can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The therapeutic efficacy of Bemiparin can be decreased when used in combination with Cephalexin.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Cephalexin.]
[N05BA10, ketazolam, The metabolism of Cephalexin can be decreased when combined with Ketazolam.]
[M01AA06, kebuzone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Kebuzone.]
[L01EA01, imatinib, The metabolism of Cephalexin can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Cephalexin can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The excretion of Cephalexin can be decreased when combined with Esomeprazole.]
[N03AX09, lamotrigine, Cephalexin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[S01BA03, cortisone, The metabolism of Cephalexin can be increased when combined with Cortisone.]
[N07BC04, lofexidine, Cephalexin may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Loxoprofen.]
[J01DC08, loracarbef, The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cephalexin.]
[C09AA03, lisinopril, Cephalexin may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Cephalexin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Cephalexin can be decreased when combined with Manidipine.]
[H02AB15, meprednisone, The metabolism of Cephalexin can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Cephalexin can be decreased when combined with Mequitazine.]
[J01DH02, meropenem, Cephalexin may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Cephalexin may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA03, midecamycin, The metabolism of Cephalexin can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, Cephalexin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Cephalexin.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Cephalexin.]
[N06BA07, modafinil, The metabolism of Cephalexin can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Cephalexin.]
[M02AA02, mofebutazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Cephalexin can be decreased when combined with Conivaptan.]
[M01AH05, etoricoxib, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Etoricoxib.]
[L01AX04, dacarbazine, Cephalexin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Cephalexin can be decreased when combined with Danazol.]
[L01DB02, daunorubicin, The metabolism of Cephalexin can be decreased when combined with Daunorubicin.]
[M01AX01, nabumetone, The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cephalexin.]
[N07BB05, nalmefene, Cephalexin may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Cephalexin may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Cephalexin can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Cephalexin may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Cephalexin may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[M03AC11, cisatracurium, Cephalexin may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Cephalexin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[A07EC03, olsalazine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Olsalazine.]
[N06AA01, desipramine, The metabolism of Cephalexin can be decreased when combined with Desipramine.]
[H01BA02, desmopressin, Cephalexin may decrease the excretion rate of Desmopressin which could result in a higher serum level.]
[V04CH02, indigo carmine, Cephalexin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Cephalexin may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[M01AE12, oxaprozin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Cephalexin can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Cephalexin can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Cephalexin can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Cephalexin can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, Cephalexin may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Cephalexin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Cephalexin may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Cephalexin may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Cinchocaine.]
[R05DA08, pholcodine, Cephalexin may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Clodronic acid.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The excretion of Cephalexin can be decreased when combined with Diclofenac.]
[J01CF01, dicloxacillin, The metabolism of Cephalexin can be increased when combined with Dicloxacillin.]
[J05AD01, foscarnet, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Foscarnet.]
[A03AA07, dicyclomine, Cephalexin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Cephalexin.]
[J05AF02, didanosine, Cephalexin may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Cephalexin.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Cephalexin.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, The metabolism of Cephalexin can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Cephalexin can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Cephalexin can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Diflunisal.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Cephalexin.]
[C01AA05, digoxin, Cephalexin may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Cephalexin.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Cephalexin.]
[N02AA03, hydromorphone, Cephalexin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, Cephalexin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Cephalexin can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, Cephalexin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Cephalexin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Cephalexin can be decreased when combined with Diltiazem.]
[V03AB09, dimercaprol, Cephalexin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, The metabolism of Cephalexin can be decreased when combined with Dimethyl sulfoxide.]
[N02BB04, propyphenazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Cephalexin.]
[C05CA03, diosmin, The metabolism of Cephalexin can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Diphenhydramine.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Cephalexin.]
[B01AC07, dipyridamole, The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Cephalexin.]
[B01AD10, drotrecogin alfa, The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Cephalexin.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Cephalexin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Cephalexin.]
[S01AX06, resorcinol, Cephalexin may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Cephalexin may decrease the excretion rate of Disopyramide which could result in a higher serum level.]
[P03AA04, disulfiram, The risk or severity of adverse effects can be increased when Cephalexin is combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Cephalexin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Cephalexin can be increased when combined with Rifapentine.]
[R06AE09, levocetirizine, Cephalexin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Cephalexin.]
[A04AD12, aprepitant, The metabolism of Cephalexin can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Cephalexin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Cephalexin.]
[J05AE07, fosamprenavir, The metabolism of Cephalexin can be decreased when combined with Fosamprenavir.]
[G04BE08, tadalafil, Cephalexin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cephalexin.]
[C01EB18, ranolazine, Cephalexin may decrease the excretion rate of Ranolazine which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Salsalate.]
[H05BA01, salmon calcitonin, Cephalexin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.]
[C01CA07, dobutamine, Cephalexin may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Cephalexin may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA12, doxepin, Cephalexin may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Cephalexin.]
[J01AA02, doxycycline, Cephalexin may decrease the excretion rate of Doxycycline which could result in a higher serum level.]
[A08AA10, sibutramine, Cephalexin may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Cephalexin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Cephalexin may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Cephalexin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Cephalexin may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[H01AA01, corticotropin, The metabolism of Cephalexin can be increased when combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Cephalexin.]
[L01AX03, temozolomide, Cephalexin may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The excretion of Cephalexin can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Cephalexin can be increased when combined with Terbinafine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Cephalexin.]
[C09AA02, enalapril, The excretion of Cephalexin can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Cephalexin may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Cephalexin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.]
[N03AX11, topiramate, The metabolism of Cephalexin can be increased when combined with Topiramate.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Cephalexin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[B01AC18, triflusal, The therapeutic efficacy of Triflusal can be decreased when used in combination with Cephalexin.]
[C05CA04, troxerutin, The therapeutic efficacy of Troxerutin can be decreased when used in combination with Cephalexin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Cephalexin.]
[N06AX16, venlafaxine, Cephalexin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C08CA12, mepirodipine, The metabolism of Cephalexin can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Cephalexin can be decreased when combined with Epinephrine.]
[B05XA12, zinc chloride, Zinc chloride can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B05XA18, zinc sulfate, Zinc sulfate can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AB04, zomepirac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AD03, anistreplase, The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cephalexin.]
[L01XA02, carboplatin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Carboplatin.]
[C02AC02, guanfacine, Cephalexin may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[N02CA02, ergotamine, The metabolism of Cephalexin can be decreased when combined with Ergotamine.]
[L03AX05, pidotimod, Cephalexin may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Cephalexin can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Cephalexin may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, The excretion of Cephalexin can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Cephalexin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cephalexin can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, Cephalexin may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Cephalexin can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Cephalexin can be increased when combined with Fluticasone.]
[V08CA03, gadodiamide, Cephalexin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[C01BD05, ibutilide, Cephalexin may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Etidocaine.]
[N01AX07, etomidate, Cephalexin may decrease the excretion rate of Etomidate which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Cephalexin.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Cephalexin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Cephalexin.]
[R06AX12, terfenadine, The metabolism of Cephalexin can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Cephalexin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Cephalexin may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Cephalexin can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, Cephalexin may decrease the excretion rate of Leuprolide which could result in a higher serum level.]
[C10AA03, pravastatin, The excretion of Cephalexin can be decreased when combined with Pravastatin.]
[M01CB01, gold sodium thiomalate, Cephalexin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Cephalexin may decrease the excretion rate of Dextran which could result in a higher serum level.]
[M05BA01, etidronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Etidronic acid.]
[V03AF02, dexrazoxane, Cephalexin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Cephalexin.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Cephalexin.]
[P02CA03, albendazole, The metabolism of Cephalexin can be decreased when combined with Albendazole.]
[M01AE04, fenoprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Fenoprofen.]
[N02AB03, fentanyl, Cephalexin may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Cephalexin may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[B01AD05, plasmin, The therapeutic efficacy of Fibrinolysin can be decreased when used in combination with Cephalexin.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Cephalexin.]
[N07AX03, cevimeline, Cephalexin may decrease the excretion rate of Cevimeline which could result in a higher serum level.]
[G04BD02, flavoxate, Cephalexin may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The excretion of Flecainide can be decreased when combined with Cephalexin.]
[N02BG04, floctafenine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Floctafenine.]
[J01CF05, floxacillin, The metabolism of Cephalexin can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Cephalexin can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Cephalexin may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Cephalexin may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07AC08, fluocinonide, The metabolism of Cephalexin can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Cephalexin can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Cephalexin can be increased when combined with Ethanol.]
[L01BC09, floxuridine, Cephalexin may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[N06AB03, fluoxetine, The metabolism of Cephalexin can be decreased when combined with Fluoxetine.]
[N05CD01, flurazepam, Cephalexin may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Flurbiprofen.]
[L02BB01, flutamide, Cephalexin may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Cephalexin may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Cephalexin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cephalexin.]
[L01BC03, tegafur, Cephalexin may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[J05AE10, darunavir, The metabolism of Cephalexin can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Furosemide may decrease the excretion rate of Cephalexin which could result in a higher serum level.]
[M05BA04, alendronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Alendronic acid.]
[N05CF04, eszopiclone, Cephalexin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[S01AD09, ganciclovir, The excretion of Cephalexin can be decreased when combined with Ganciclovir.]
[N03AA04, barbexaclone, The metabolism of Cephalexin can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The excretion of Cephalexin can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Cephalexin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Cephalexin.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Cephalexin.]
[J05AG04, etravirine, The metabolism of Cephalexin can be increased when combined with Etravirine.]
[L01EH01, lapatinib, The metabolism of Cephalexin can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The excretion of Cephalexin can be decreased when combined with Glyburide.]
[A10BB07, glipizide, Cephalexin may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Cephalexin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Cephalexin.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Cephalexin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Cephalexin.]
[M01CB04, aurothioglucose, Cephalexin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Cephalexin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Cephalexin is combined with Fluindione.]
[C09AA09, fosinopril, Cephalexin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[D01BA01, griseofulvin, The metabolism of Cephalexin can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, Cephalexin may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Cephalexin may decrease the excretion rate of Goserelin which could result in a higher serum level.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Cephalexin.]
[N05AH04, quetiapine, Cephalexin may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Cephalexin may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Cephalexin.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Cephalexin.]
[C09CA01, losartan, The metabolism of Cephalexin can be decreased when combined with Losartan.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be decreased when used in combination with Cephalexin.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Cephalexin.]
[A07EC02, mesalamine, The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cephalexin.]
[C01CE02, milrinone, Cephalexin may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[C08CA10, nilvadipine, The metabolism of Cephalexin can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Nimesulide.]
[C09AA04, perindopril, Cephalexin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, The metabolism of Cephalexin can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Cephalexin.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Cephalexin.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Cephalexin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Cephalexin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.]
[G04BD06, propiverine, Cephalexin may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Cephalexin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[J04AB04, rifabutin, The metabolism of Cephalexin can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Risedronic acid.]
[R02AX02, ibuprofen, The excretion of Cephalexin can be decreased when combined with Ibuprofen.]
[B05XA08, sodium acetate, Cephalexin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The therapeutic efficacy of Sodium citrate can be decreased when used in combination with Cephalexin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Cephalexin.]
[N06AA02, imipramine, Cephalexin may decrease the excretion rate of Imipramine which could result in a higher serum level.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Cephalexin.]
[R01AD07, tixocortol, Cephalexin may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, The excretion of Topotecan can be decreased when combined with Cephalexin.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The excretion of Cephalexin can be decreased when combined with Indomethacin.]
[A16AX05, zinc acetate, Zinc acetate can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CB02, zinc gluconate, Zinc gluconate can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A11HA07, inositol, Cephalexin may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Cephalexin can be decreased when combined with Milnacipran.]
[S01XA28, varenicline, Cephalexin may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Articaine.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Cephalexin.]
[N05BA12, alprazolam, Cephalexin may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, Cephalexin may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C10AA06, cerivastatin, The metabolism of Cephalexin can be increased when combined with Cerivastatin.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Cephalexin may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Cephalexin.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Cephalexin.]
[J04AC01, isoniazid, The metabolism of Cephalexin can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Cephalexin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Cephalexin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10BA01, isotretinoin, Cephalexin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[B01AE06, bivalirudin, The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cephalexin.]
[S01AA24, kanamycin, Cephalexin may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Cephalexin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Cephalexin may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Cephalexin may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[H02CA04, levoketoconazole, The metabolism of Cephalexin can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Cephalexin can be decreased when combined with Ketoconazole.]
[M02AA10, ketoprofen, The excretion of Cephalexin can be decreased when combined with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Cephalexin can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Cephalexin can be increased when combined with Abatacept.]
[D10AX03, azelaic acid, Cephalexin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
[J01MB02, nalidixic acid, The excretion of Cephalexin can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Tiaprofenic acid.]
[C07AG01, labetalol, Cephalexin may decrease the excretion rate of Labetalol which could result in a higher serum level.]
[N04BB01, amantadine, Cephalexin may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Cephalexin.]
[A06AX03, lubiprostone, Cephalexin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Cephalexin.]
[C03CC01, ethacrynic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Etacrynic acid.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Lidocaine.]
[S01AA21, amikacin, Cephalexin may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Cephalexin can be increased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA06, lorazepam, Cephalexin may decrease the excretion rate of Lorazepam which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Cephalexin can be decreased when combined with Lovastatin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Cephalexin.]
[B05XA11, magnesium chloride, Cephalexin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Cephalexin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Cephalexin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Cephalexin can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Cephalexin.]
[N06AA21, maprotiline, Cephalexin may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Cephalexin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[M02AA18, meclofenamic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Meclofenamic acid.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cephalexin.]
[B01AB05, enoxaparin, The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Cephalexin.]
[B01AB04, dalteparin, The therapeutic efficacy of Dalteparin can be decreased when used in combination with Cephalexin.]
[N05CH01, melatonin, The excretion of Cephalexin can be decreased when combined with Melatonin.]
[N06DX01, memantine, Cephalexin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, The metabolism of Cephalexin can be decreased when combined with Meperidine.]
[N03AA01, mephobarbital, The metabolism of Cephalexin can be increased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Mepivacaine.]
[G04BX16, tiopronin, Cephalexin may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[L02BG01, aminoglutethimide, The metabolism of Cephalexin can be increased when combined with Aminoglutethimide.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Cephalexin may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Cephalexin may decrease the excretion rate of Metformin which could result in a higher serum level.]
[H01CB03, lanreotide, The metabolism of Cephalexin can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Cephalexin can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, Cephalexin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Cephalexin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Cephalexin can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Cephalexin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Cephalexin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Cephalexin.]
[D05BA02, methoxsalen, Cephalexin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Cephalexin may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, The metabolism of Cephalexin can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Cephalexin can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Cephalexin.]
[H02AB04, methylprednisolone, The metabolism of Cephalexin can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Cephalexin can be increased when combined with Rufinamide.]
[G03EK01, methyltestosterone, The excretion of Cephalexin can be increased when combined with Methyltestosterone.]
[N02CA04, methysergide, The metabolism of Cephalexin can be decreased when combined with Methysergide.]
[A03FA01, metoclopramide, Cephalexin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Cephalexin may decrease the excretion rate of Metoprolol which could result in a higher serum level.]
[P01AB01, metronidazole, The metabolism of Cephalexin can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Cephalexin can be increased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Cephalexin can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Aminophenazone.]
[B01AB07, parnaparin, The therapeutic efficacy of Parnaparin can be decreased when used in combination with Cephalexin.]
[N05CD08, midazolam, The metabolism of Cephalexin can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Cephalexin can be increased when combined with Mifepristone.]
[B01AB10, tinzaparin, The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Cephalexin.]
[J05AH01, zanamivir, Cephalexin may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[J01AA08, minocycline, The excretion of Cephalexin can be decreased when combined with Minocycline.]
[J01FA11, miocamycin, The metabolism of Cephalexin can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Cephalexin can be increased when combined with Mitotane.]
[L03AC01, aldesleukin, The metabolism of Cephalexin can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Cephalexin can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Cephalexin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.]
[A04AA05, palonosetron, Cephalexin may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[J01DD06, moxalactam, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Latamoxef.]
[L04AB05, certolizumab pegol, The metabolism of Cephalexin can be increased when combined with Certolizumab pegol.]
[G04BA01, ammonium chloride, Cephalexin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Cephalexin.]
[L04AA06, mycophenolic acid, Cephalexin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N05CA02, amobarbital, The metabolism of Cephalexin can be increased when combined with Amobarbital.]
[G03XC01, raloxifene, The metabolism of Cephalexin can be decreased when combined with Raloxifene.]
[N03AB05, fosphenytoin, The metabolism of Cephalexin can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Cephalexin may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, Cephalexin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[J01CF06, nafcillin, The metabolism of Cephalexin can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Cephalexin can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Cephalexin can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Cephalexin may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[M02AA12, naproxen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Cephalexin can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, Cephalexin may decrease the excretion rate of Duloxetine which could result in a higher serum level.]
[N04BX01, tolcapone, Cephalexin may decrease the excretion rate of Tolcapone which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Cephalexin.]
[S03AA01, neomycin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Neomycin.]
[B01AC17, tirofiban, Cephalexin may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Amphotericin B.]
[S01AA19, ampicillin, Cephalexin may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Cephalexin may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Cephalexin may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Cephalexin can be decreased when combined with Desvenlafaxine.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Cephalexin.]
[C01CE01, inamrinone, Cephalexin may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The metabolism of Cephalexin can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Cephalexin can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, Cephalexin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Niflumic acid.]
[C08CA07, nisoldipine, Cephalexin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[R07AX01, nitric oxide, Cephalexin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Cephalexin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Cephalexin may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Cephalexin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02DD01, nitroprusside, Cephalexin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Cephalexin.]
[S01AE02, norfloxacin, The excretion of Cephalexin can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Cephalexin can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Cephalexin.]
[R05DA07, noscapine, The metabolism of Cephalexin can be decreased when combined with Noscapine.]
[B01AB08, reviparin, The therapeutic efficacy of Reviparin can be decreased when used in combination with Cephalexin.]
[H01CB02, octreotide, The metabolism of Cephalexin can be decreased when combined with Octreotide.]
[S02AA16, ofloxacin, The excretion of Cephalexin can be decreased when combined with Ofloxacin.]
[J01FA05, oleandomycin, The metabolism of Cephalexin can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Cephalexin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Cephalexin can be increased when combined with Omeprazole.]
[N02AA02, opium, Cephalexin may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AD07, reteplase, The therapeutic efficacy of Reteplase can be decreased when used in combination with Cephalexin.]
[B01AD09, ancrod, The therapeutic efficacy of Ancrod can be decreased when used in combination with Cephalexin.]
[G04CA02, tamsulosin, Cephalexin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01AC01, ouabain, The excretion of Cephalexin can be decreased when combined with Ouabain.]
[M05BA08, zoledronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Zoledronic acid.]
[J01CF04, oxacillin, Cephalexin may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Cephalexin may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Cephalexin.]
[V04CH30, 4-aminohippuric acid, The excretion of Cephalexin can be decreased when combined with Aminohippuric acid.]
[B01AB09, danaparoid, The therapeutic efficacy of Danaparoid can be decreased when used in combination with Cephalexin.]
[J04AB30, capreomycin, Cephalexin may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[H02AB05, paramethasone, The metabolism of Cephalexin can be increased when combined with Paramethasone.]
[A07AA06, paromomycin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Paromomycin.]
[G04BD11, fesoterodine, Cephalexin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Cephalexin may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Cephalexin.]
[J01CE09, penicillin G procaine, Cephalexin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Cephalexin can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Cephalexin may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Cephalexin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N02BE03, phenacetin, The excretion of Cephalexin can be decreased when combined with Phenacetin.]
[G04BX06, phenazopyridine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Phenazopyridine.]
[N06AF03, phenelzine, Cephalexin may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Cephalexin is combined with Phenindione.]
[N03AA02, phenobarbital, The metabolism of Cephalexin can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Cephalexin.]
[V03AB36, phentolamine, Cephalexin may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, The excretion of Cephalexin can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Cephalexin can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Cephalexin can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Cephalexin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Cephalexin.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Cephalexin.]
[B02BA01, vitamin K1, Cephalexin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Cephalexin.]
[C08CX01, mibefradil, The metabolism of Cephalexin can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Cephalexin.]
[C07AA03, pindolol, Cephalexin may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Cephalexin.]
[J05AE01, saquinavir, The metabolism of Cephalexin can be decreased when combined with Saquinavir.]
[N06BX03, piracetam, Cephalexin may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The excretion of Cephalexin can be decreased when combined with Piroxicam.]
[J01DD16, cefditoren, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefditoren.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Cephalexin.]
[J05AG02, delavirdine, The metabolism of Cephalexin can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Cephalexin can be decreased when combined with Irbesartan.]
[B01AC13, abciximab, The therapeutic efficacy of Abciximab can be decreased when used in combination with Cephalexin.]
[S01XA13, alteplase, The therapeutic efficacy of Alteplase can be decreased when used in combination with Cephalexin.]
[A10BG02, rosiglitazone, Cephalexin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[L04AC08, canakinumab, The metabolism of Cephalexin can be increased when combined with Canakinumab.]
[S03AA03, polymyxin B, The risk or severity of adverse effects can be increased when Cephalexin is combined with Polymyxin B.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Cephalexin.]
[J05AE03, ritonavir, The serum concentration of Cephalexin can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Cephalexin.]
[B05XA01, potassium chloride, Cephalexin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[S03BA02, prednisolone, The metabolism of Cephalexin can be increased when combined with Prednisolone.]
[H02AB07, prednisone, Cephalexin may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Cephalexin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Cephalexin can be increased when combined with Primidone.]
[M04AB01, probenecid, The serum concentration of Cephalexin can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, The excretion of Procainamide can be decreased when combined with Cephalexin.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Procaine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Cephalexin.]
[R06AD02, promethazine, Cephalexin may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Cephalexin may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Cephalexin.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Cephalexin.]
[N01AX10, propofol, The metabolism of Cephalexin can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Cephalexin can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, Cephalexin may decrease the excretion rate of Propranolol which could result in a higher serum level.]
[N02CC04, rizatriptan, Cephalexin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Cephalexin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Cephalexin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Cephalexin may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Cephalexin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[P01BD01, pyrimethamine, The excretion of Cephalexin can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, Cephalexin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The metabolism of Cephalexin can be increased when combined with Quinine.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Cephalexin.]
[C02AA02, reserpine, Cephalexin may decrease the excretion rate of Reserpine which could result in a higher serum level.]
[J05AP01, ribavirin, Cephalexin may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[S01XA26, riboflavin, The excretion of Cephalexin can be decreased when combined with Riboflavin.]
[J04AB02, rifampin, The metabolism of Cephalexin can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Cephalexin can be decreased when combined with Roxithromycin.]
[N02BA05, salicylamide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The excretion of Cephalexin can be decreased when combined with Salicylic acid.]
[N05CA06, secobarbital, The metabolism of Cephalexin can be increased when combined with Secobarbital.]
[J01GB08, sisomicin, Cephalexin may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Cephalexin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[H01CB01, somatostatin, The metabolism of Cephalexin can be decreased when combined with Somatostatin.]
[V04CC01, sorbitol, Cephalexin may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Cephalexin.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N03AG01, valproic acid, The excretion of Valproic acid can be decreased when combined with Cephalexin.]
[D07AB02, hydrocortisone butyrate, The metabolism of Cephalexin can be increased when combined with Hydrocortisone butyrate.]
[S02DA03, antipyrine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Antipyrine.]
[B01AD01, streptokinase, The therapeutic efficacy of Streptokinase can be decreased when used in combination with Cephalexin.]
[J01GA01, streptomycin, Cephalexin may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[A02BX02, sucralfate, Cephalexin may decrease the excretion rate of Sucralfate which could result in a higher serum level.]
[J01CG01, sulbactam, Cephalexin may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, Cephalexin may decrease the excretion rate of Sulfadiazine which could result in a higher serum level.]
[J01EC01, sulfamethoxazole, The metabolism of Cephalexin can be decreased when combined with Sulfamethoxazole.]
[M04AB02, sulfinpyrazone, The metabolism of Cephalexin can be increased when combined with Sulfinpyrazone.]
[M01AB02, sulindac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Sulindac.]
[M01AX04, apazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Azapropazone.]
[L01BB02, mercaptopurine, The excretion of Mercaptopurine can be decreased when combined with Cephalexin.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Cephalexin.]
[N05CD07, temazepam, Cephalexin may decrease the excretion rate of Temazepam which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Cephalexin.]
[R03CC03, terbutaline, Cephalexin may decrease the excretion rate of Terbutaline which could result in a higher serum level.]
[B01AE07, dabigatran etexilate, Cephalexin may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, The metabolism of Cephalexin can be increased when combined with Testosterone.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Tetracaine.]
[S03AA02, tetracycline, The excretion of Tetracycline can be decreased when combined with Cephalexin.]
[J01DI02, ceftaroline fosamil, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Ceftaroline fosamil.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Cephalexin.]
[P02CA02, thiabendazole, Cephalexin may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[R06AD03, thiethylperazine, Cephalexin may decrease the excretion rate of Thiethylperazine which could result in a higher serum level.]
[L01AC01, thiotepa, The metabolism of Thiotepa can be decreased when combined with Cephalexin.]
[G04BE06, moxisylyte, Cephalexin may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Cephalexin may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, Cephalexin may decrease the excretion rate of Ticlopidine which could result in a higher serum level.]
[S01ED01, timolol, Cephalexin may decrease the excretion rate of Timolol which could result in a higher serum level.]
[P01AB02, tinidazole, Cephalexin may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Cephalexin may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Cephalexin may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, Cephalexin may decrease the excretion rate of Tolbutamide which could result in a higher serum level.]
[M02AA21, tolmetin, The risk or severity of nephrotoxicity can be increased when Tolmetin is combined with Cephalexin.]
[N02AX02, tramadol, Cephalexin may decrease the excretion rate of Tramadol which could result in a higher serum level.]
[S01BA05, triamcinolone, The metabolism of Cephalexin can be increased when combined with Triamcinolone.]
[C03DB02, triamterene, The risk or severity of nephrotoxicity can be increased when Triamterene is combined with Cephalexin.]
[N05CD05, triazolam, Cephalexin may decrease the excretion rate of Triazolam which could result in a higher serum level.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Cephalexin may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[S01AD02, trifluridine, The excretion of Trifluridine can be decreased when combined with Cephalexin.]
[R03BA07, mometasone, The metabolism of Cephalexin can be increased when combined with Mometasone.]
[A03AA05, trimebutine, Cephalexin may decrease the excretion rate of Trimebutine which could result in a higher serum level.]
[J01EA01, trimethoprim, Cephalexin may decrease the excretion rate of Trimethoprim which could result in a higher serum level.]
[J01FA08, troleandomycin, The metabolism of Cephalexin can be decreased when combined with Troleandomycin.]
[R03DX07, roflumilast, The metabolism of Roflumilast can be decreased when combined with Cephalexin.]
[L01FX04, ipilimumab, Cephalexin may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The metabolism of Vandetanib can be decreased when combined with Cephalexin.]
[R02AA14, oxyquinoline, Cephalexin may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[A10BH05, linagliptin, The metabolism of Cephalexin can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Cephalexin can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Cephalexin can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Cephalexin can be decreased when combined with Rilpivirine.]
[B01AD04, urokinase, The therapeutic efficacy of Urokinase can be decreased when used in combination with Cephalexin.]
[S01AA28, vancomycin, Cephalexin may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, Cephalexin may decrease the excretion rate of Ezogabine which could result in a higher serum level.]
[B01AF01, rivaroxaban, Cephalexin may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[B01AC24, ticagrelor, The metabolism of Cephalexin can be decreased when combined with Ticagrelor.]
[C08DA01, verapamil, The metabolism of Cephalexin can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Cephalexin can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Vinblastine can be decreased when combined with Cephalexin.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Cephalexin.]
[L01CA03, vindesine, The metabolism of Vindesine can be decreased when combined with Cephalexin.]
[B03BA01, vitamin B12, Cephalexin may decrease the excretion rate of Cyanocobalamin which could result in a higher serum level.]
[A11HA03, vitamin E, The metabolism of Cephalexin can be increased when combined with Vitamin E.]
[B01AA03, warfarin, Cephalexin may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The excretion of Cephalexin can be decreased when combined with Zidovudine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Cephalexin.]
[J05AE02, indinavir, The metabolism of Cephalexin can be decreased when combined with Indinavir.]
[L01EC01, vemurafenib, The metabolism of Vemurafenib can be decreased when combined with Cephalexin.]
[M05BA03, pamidronic acid, The risk or severity of nephrotoxicity can be increased when Pamidronic acid is combined with Cephalexin.]
[L01FX05, brentuximab vedotin, The metabolism of Brentuximab vedotin can be decreased when combined with Cephalexin.]
[M05BA05, tiludronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Tiludronic acid.]
[B06AC02, icatibant, Cephalexin may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Cephalexin.]
[B01AE01, desirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin.]
[R03DC01, zafirlukast, The metabolism of Cephalexin can be decreased when combined with Zafirlukast.]
[A02BC04, rabeprazole, Cephalexin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Ibandronate.]
[N05AE04, ziprasidone, The metabolism of Cephalexin can be decreased when combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Cephalexin may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, The excretion of Cephalexin can be decreased when combined with Acetylsalicylic acid.]
[L01EJ01, ruxolitinib, The metabolism of Ruxolitinib can be decreased when combined with Cephalexin.]
[G04BD07, tolterodine, Cephalexin may decrease the excretion rate of Tolterodine which could result in a higher serum level.]
[J01DH04, doripenem, The excretion of Doripenem can be decreased when combined with Cephalexin.]
[J02AC03, voriconazole, The metabolism of Cephalexin can be decreased when combined with Voriconazole.]
[M01CB03, auranofin, Cephalexin may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Cephalexin.]
[R07AX02, ivacaftor, The metabolism of Cephalexin can be decreased when combined with Ivacaftor.]
[H02AB11, prednylidene, The metabolism of Cephalexin can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Cephalexin may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Cephalexin may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Cephalexin may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Cephalexin may decrease the excretion rate of Gemcitabine which could result in a higher serum level.]
[J01DF01, aztreonam, Cephalexin may decrease the excretion rate of Aztreonam which could result in a higher serum level.]
[R02AB04, bacitracin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Bacitracin.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Cephalexin.]
[M03BX01, baclofen, Cephalexin may decrease the excretion rate of Baclofen which could result in a higher serum level.]
[A08AA11, lorcaserin, Cephalexin may decrease the excretion rate of Lorcaserin which could result in a higher serum level.]
[G04BD12, mirabegron, Cephalexin may decrease the excretion rate of Mirabegron which could result in a higher serum level.]
[V03AX03, cobicistat, The metabolism of Cephalexin can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Cephalexin can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Cephalexin can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Bosutinib can be decreased when combined with Cephalexin.]
[L04AA31, teriflunomide, The excretion of Cephalexin can be decreased when combined with Teriflunomide.]
[B01AX01, defibrotide, The therapeutic efficacy of Defibrotide can be decreased when used in combination with Cephalexin.]
[L01EX05, regorafenib, The metabolism of Regorafenib can be decreased when combined with Cephalexin.]
[N05CA04, barbital, The metabolism of Cephalexin can be increased when combined with Barbital.]
[D02BA02, octinoxate, Cephalexin may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Cephalexin can be decreased when combined with Nelfinavir.]
[N04BD02, rasagiline, Cephalexin may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[N03AX22, perampanel, The metabolism of Cephalexin can be increased when combined with Perampanel.]
[V09IX04, fluorodeoxyglucose F18, Cephalexin may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[H01CB05, pasireotide, The metabolism of Cephalexin can be decreased when combined with Pasireotide.]
[V08CA11, gadofosveset, Cephalexin may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Cephalexin.]
[B01AF02, apixaban, The therapeutic efficacy of Apixaban can be decreased when used in combination with Cephalexin.]
[A16AX08, teduglutide, Cephalexin may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[C10AX12, lomitapide, The metabolism of Lomitapide can be decreased when combined with Cephalexin.]
[A10BH04, alogliptin, Cephalexin may decrease the excretion rate of Alogliptin which could result in a higher serum level.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Cephalexin can be increased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, The metabolism of Pomalidomide can be decreased when combined with Cephalexin.]
[N02BA10, benorilate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Benorilate.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[R02AD01, benzocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Benzocaine.]
[J02AX04, caspofungin, The excretion of Cephalexin can be decreased when combined with Caspofungin.]
[L03AA12, ancestim, Cephalexin may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The risk or severity of nephrotoxicity can be increased when Celecoxib is combined with Cephalexin.]
[L04AA18, everolimus, The metabolism of Everolimus can be decreased when combined with Cephalexin.]
[N04AC01, benztropine, Cephalexin may decrease the excretion rate of Benzatropine which could result in a higher serum level.]
[L01EC02, dabrafenib, The serum concentration of Cephalexin can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Benzydamine.]
[L01EE01, trametinib, Cephalexin may decrease the excretion rate of Trametinib which could result in a higher serum level.]
[P03AX06, benzyl alcohol, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Benzyl alcohol.]
[V09AX05, florbetapir F-18, Cephalexin may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, Cephalexin may decrease the excretion rate of Levomilnacipran which could result in a higher serum level.]
[J05AJ03, dolutegravir, The excretion of Cephalexin can be decreased when combined with Dolutegravir.]
[A10BJ03, lixisenatide, Cephalexin may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[A05AA03, cholic acid, The excretion of Cholic Acid can be decreased when combined with Cephalexin.]
[C02KX04, macitentan, Cephalexin may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[N06AX26, vortioxetine, Cephalexin may decrease the excretion rate of Vortioxetine which could result in a higher serum level.]
[G03AC08, etonogestrel, Cephalexin may decrease the excretion rate of Etonogestrel which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The metabolism of Cephalexin can be increased when combined with Eslicarbazepine.]
[J05AP05, simeprevir, The metabolism of Cephalexin can be decreased when combined with Simeprevir.]
[V03AE05, sucroferric oxyhydroxide, The therapeutic efficacy of Cephalexin can be decreased when used in combination with Iron sucrose.]
[J05AP08, sofosbuvir, Cephalexin may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[A10BK01, dapagliflozin, Dapagliflozin may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[C01CA27, droxidopa, Cephalexin may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[N05CH03, tasimelteon, The metabolism of Tasimelteon can be decreased when combined with Cephalexin.]
[A16AA07, metreleptin, The metabolism of Cephalexin can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Cephalexin can be increased when combined with Apremilast.]
[L02BG02, formestane, The metabolism of Cephalexin can be increased when combined with Formestane.]
[S03BA03, betamethasone, The metabolism of Cephalexin can be increased when combined with Betamethasone.]
[B01AE03, argatroban, The therapeutic efficacy of Argatroban can be decreased when used in combination with Cephalexin.]
[V03AB34, fomepizole, Cephalexin may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[L04AC11, siltuximab, The metabolism of Cephalexin can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The metabolism of Ceritinib can be decreased when combined with Cephalexin.]
[B01AC26, vorapaxar, The metabolism of Vorapaxar can be decreased when combined with Cephalexin.]
[B01AA07, acenocoumarol, The metabolism of Acenocoumarol can be decreased when combined with Cephalexin.]
[L01EM01, idelalisib, The metabolism of Idelalisib can be decreased when combined with Cephalexin.]
[N07XX08, tafamidis, The excretion of Cephalexin can be decreased when combined with Tafamidis.]
[V08AA01, diatrizoic acid, Cephalexin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[V08AA04, iothalamic acid, Cephalexin may decrease the excretion rate of Diatrizoate which could result in a higher serum level.]
[N05CM19, suvorexant, The metabolism of Suvorexant can be decreased when combined with Cephalexin.]
[J01XA05, oritavancin, The metabolism of Cephalexin can be increased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Dihydrostreptomycin.]
[L01EX09, nintedanib, The metabolism of Nintedanib can be decreased when combined with Cephalexin.]
[S03AA06, gentamicin, Cephalexin may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Cephalexin.]
[B01AA01, dicumarol, The risk or severity of bleeding can be increased when Cephalexin is combined with Dicoumarol.]
[B01AF03, edoxaban, Cephalexin may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The metabolism of Cephalexin can be decreased when combined with Mirtazapine.]
[L04AC10, secukinumab, The metabolism of Cephalexin can be increased when combined with Secukinumab.]
[L01EF01, palbociclib, The metabolism of Palbociclib can be decreased when combined with Cephalexin.]
[L01EX08, lenvatinib, The excretion of Cephalexin can be decreased when combined with Lenvatinib.]
[L01XH03, panobinostat, The metabolism of Panobinostat can be decreased when combined with Cephalexin.]
[N02BE01, acetaminophen, The metabolism of Cephalexin can be increased when combined with Acetaminophen.]
[L01DC01, bleomycin, Cephalexin may decrease the excretion rate of Bleomycin which could result in a higher serum level.]
[B01AA11, tioclomarol, The risk or severity of bleeding can be increased when Cephalexin is combined with Tioclomarol.]
[J05AF08, adefovir dipivoxil, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Adefovir dipivoxil.]
[J05AP06, asunaprevir, The metabolism of Cephalexin can be increased when combined with Asunaprevir.]
[A07DA06, eluxadoline, The excretion of Eluxadoline can be decreased when combined with Cephalexin.]
[B01AC25, cangrelor, The therapeutic efficacy of Cangrelor can be decreased when used in combination with Cephalexin.]
[L01XJ02, sonidegib, The metabolism of Sonidegib can be decreased when combined with Cephalexin.]
[M02AA25, aceclofenac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Aceclofenac.]
[M01AB11, acemetacin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Acemetacin.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC03, lansoprazole, The excretion of Cephalexin can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Cephalexin may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Cephalexin.]
[J02AC05, isavuconazole, The metabolism of Cephalexin can be decreased when combined with Isavuconazole.]
[L01EB04, osimertinib, The metabolism of Osimertinib can be decreased when combined with Cephalexin.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Cephalexin.]
[L01EE02, cobimetinib, The metabolism of Cobimetinib can be decreased when combined with Cephalexin.]
[L01XG03, ixazomib, The metabolism of Ixazomib can be decreased when combined with Cephalexin.]
[L01ED03, alectinib, The metabolism of Alectinib can be decreased when combined with Cephalexin.]
[M04AB05, lesinurad, The metabolism of Cephalexin can be increased when combined with Lesinurad.]
[N05CA05, aprobarbital, The metabolism of Cephalexin can be increased when combined with Aprobarbital.]
[M01AE16, alminoprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Alminoprofen.]
[N03AX23, brivaracetam, Cephalexin may decrease the excretion rate of Brivaracetam which could result in a higher serum level.]
[L01XX52, venetoclax, The metabolism of Venetoclax can be decreased when combined with Cephalexin.]
[N05BA08, bromazepam, Cephalexin may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Cephalexin may decrease the excretion rate of Almasilate which could result in a higher serum level.]
[N05AX17, pimavanserin, The metabolism of Pimavanserin can be decreased when combined with Cephalexin.]
[C03CA02, bumetanide, The excretion of Bumetanide can be decreased when combined with Cephalexin.]
[N01BB01, bupivacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Bupivacaine.]
[N07BC01, buprenorphine, The metabolism of Cephalexin can be decreased when combined with Buprenorphine.]
[N05BE01, buspirone, Cephalexin may decrease the excretion rate of Buspirone which could result in a higher serum level.]
[L01AB01, busulfan, The metabolism of Busulfan can be decreased when combined with Cephalexin.]
[L01XX27, arsenic trioxide, Cephalexin may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.]
[M02AA03, clofezone, Cephalexin may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[L01XK03, rucaparib, The metabolism of Cephalexin can be decreased when combined with Rucaparib.]
[S01AA26, azithromycin, The metabolism of Cephalexin can be decreased when combined with Azithromycin.]
[L01EF02, ribociclib, The metabolism of Cephalexin can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Balsalazide.]
[A06AH05, naldemedine, Cephalexin may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, Cephalexin may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.]
[N02BF02, pregabalin, Cephalexin may decrease the excretion rate of Pregabalin which could result in a higher serum level.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Oxybuprocaine.]
[D05AX03, calcitriol, The metabolism of Cephalexin can be increased when combined with Calcitriol.]
[P01CA02, benznidazole, Cephalexin may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J01XX08, linezolid, The excretion of Cephalexin can be decreased when combined with Linezolid.]
[J05AF06, abacavir, Cephalexin may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Cephalexin can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, Cephalexin may decrease the excretion rate of Valbenazine which could result in a higher serum level.]
[L04AB02, infliximab, The metabolism of Cephalexin can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Cephalexin can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Cephalexin.]
[L04AC14, sarilumab, The metabolism of Cephalexin can be increased when combined with Sarilumab.]
[J01MA23, delafloxacin, Cephalexin may decrease the excretion rate of Delafloxacin which could result in a higher serum level.]
[B01AF04, betrixaban, The therapeutic efficacy of Betrixaban can be decreased when used in combination with Cephalexin.]
[D01AC10, bifonazole, The metabolism of Cephalexin can be decreased when combined with Bifonazole.]
[L01BC06, capecitabine, Cephalexin may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Cephalexin.]
[L01EH02, neratinib, The metabolism of Neratinib can be decreased when combined with Cephalexin.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Cephalexin.]
[L01EF03, abemaciclib, The excretion of Abemaciclib can be decreased when combined with Cephalexin.]
[C07AB07, bisoprolol, Cephalexin may decrease the excretion rate of Bisoprolol which could result in a higher serum level.]
[J05AG03, efavirenz, The metabolism of Cephalexin can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefprozil.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Cephalexin can be increased when combined with Budesonide.]
[M01AB07, bumadizone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Bumadizone.]
[L01EL02, acalabrutinib, The metabolism of Acalabrutinib can be decreased when combined with Cephalexin.]
[J05AX18, letermovir, The excretion of Cephalexin can be decreased when combined with Letermovir.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, Cephalexin may decrease the excretion rate of Acrivastine which could result in a higher serum level.]
[C09AA01, captopril, The excretion of Captopril can be decreased when combined with Cephalexin.]
[L02BB05, apalutamide, The metabolism of Cephalexin can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Cephalexin can be increased when combined with Carbamazepine.]
[J01CA03, carbenicillin, The excretion of Cephalexin can be decreased when combined with Carbenicillin.]
[B02BX09, fostamatinib, The metabolism of Cephalexin can be decreased when combined with Fostamatinib.]
[N03AX24, cannabidiol, The metabolism of Cephalexin can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The excretion of Cephalexin can be decreased when combined with Avatrombopag.]
[L04AA37, baricitinib, The serum concentration of Baricitinib can be increased when it is combined with Cephalexin.]
[J01DE01, cefepime, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefepime.]
[J01DD10, cefetamet, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefetamet.]
[J01DD09, cefodizime, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefodizime.]
[J01DC11, ceforanide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Ceforanide.]
[J01DD13, cefpodoxime, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefpodoxime.]
[J01DD14, ceftibuten, The excretion of Ceftibuten can be decreased when combined with Cephalexin.]
[J01GB14, plazomicin, Cephalexin may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[L01XX62, ivosidenib, The metabolism of Cephalexin can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The excretion of Cephalexin can be decreased when combined with Tafenoquine.]
[A16AX14, migalastat, Cephalexin may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Cephalexin can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Cephalexin can be increased when combined with Tecovirimat.]
[L01EM04, duvelisib, The metabolism of Duvelisib can be decreased when combined with Cephalexin.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Cephalexin.]
[S01GX12, cetirizine, Cephalexin may decrease the excretion rate of Cetirizine which could result in a higher serum level.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Cephalexin may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Lornoxicam.]
[N07XX15, inotersen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Inotersen.]
[L01ED05, lorlatinib, The metabolism of Cephalexin can be increased when combined with Lorlatinib.]
[L04AA39, emapalumab, The metabolism of Cephalexin can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Cephalexin may decrease the excretion rate of Carmustine which could result in a higher serum level.]
[L01EX13, gilteritinib, The metabolism of Gilteritinib can be decreased when combined with Cephalexin.]
[L01XJ03, glasdegib, The excretion of Cephalexin can be decreased when combined with Glasdegib.]
[A06AX05, prucalopride, Cephalexin may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[B01AC23, cilostazol, Cephalexin may decrease the excretion rate of Cilostazol which could result in a higher serum level.]
[P02BX04, triclabendazole, The metabolism of Cephalexin can be decreased when combined with Triclabendazole.]
[N06AX27, esketamine, The metabolism of Cephalexin can be increased when combined with Esketamine.]
[L04AA42, siponimod, The metabolism of Siponimod can be decreased when combined with Cephalexin.]
[J01FA09, clarithromycin, The metabolism of Cephalexin can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Cephalexin may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[L01EN01, erdafitinib, The metabolism of Erdafitinib can be decreased when combined with Cephalexin.]
[N05BA09, clobazam, The metabolism of Cephalexin can be increased when combined with Clobazam.]
[H02AB14, cloprednol, The metabolism of Cephalexin can be increased when combined with Cloprednol.]
[L04AB01, etanercept, The metabolism of Cephalexin can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Cephalexin can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Alpelisib can be decreased when combined with Cephalexin.]
[J01DC04, cefaclor, The excretion of Cefaclor can be decreased when combined with Cephalexin.]
[J01DB05, cefadroxil, The excretion of Cephalexin can be decreased when combined with Cefadroxil.]
[J01DC03, cefamandole, The excretion of Cephalexin can be decreased when combined with Cefamandole.]
[J01DB07, cefatrizine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefatrizine.]
[J01DB04, cefazolin, The excretion of Cefazolin can be decreased when combined with Cephalexin.]
[J01DC09, cefmetazole, The risk or severity of nephrotoxicity can be increased when Cefmetazole is combined with Cephalexin.]
[J01DC06, cefonicid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefonicid.]
[L01EX15, pexidartinib, The metabolism of Pexidartinib can be decreased when combined with Cephalexin.]
[J01DD12, cefoperazone, The excretion of Cephalexin can be decreased when combined with Cefoperazone.]
[J01DD01, cefotaxime, The excretion of Cephalexin can be decreased when combined with Cefotaxime.]
[J01DC05, cefotetan, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefotetan.]
[J01DC07, cefotiam, The excretion of Cephalexin can be decreased when combined with Cefotiam.]
[J01DC01, cefoxitin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefoxitin.]
[J01DD03, cefsulodin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefsulodin.]
[J01DD02, ceftazidime, The risk or severity of nephrotoxicity can be increased when Ceftazidime is combined with Cephalexin.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, The excretion of Ceftizoxime can be decreased when combined with Cephalexin.]
[J01DD04, ceftriaxone, The excretion of Cephalexin can be decreased when combined with Ceftriaxone.]
[S01AA27, cefuroxime, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefuroxime.]
[L01EJ02, fedratinib, The excretion of Cephalexin can be decreased when combined with Fedratinib.]
[L01EX14, entrectinib, The metabolism of Entrectinib can be decreased when combined with Cephalexin.]
[N07XX11, pitolisant, The serum concentration of Cephalexin can be decreased when it is combined with Pitolisant.]
[J04AK08, pretomanid, The metabolism of Pretomanid can be decreased when combined with Cephalexin.]
[J01XX12, lefamulin, The metabolism of Lefamulin can be decreased when combined with Cephalexin.]
[N04CX01, istradefylline, The excretion of Cephalexin can be decreased when combined with Istradefylline.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01XX09, daptomycin, Cephalexin may decrease the excretion rate of Daptomycin which could result in a higher serum level.]
[S01AA13, fusidic acid, The metabolism of Cephalexin can be decreased when combined with Fusidic acid.]
[J01DB02, cephaloridine, The excretion of Cefaloridine can be decreased when combined with Cephalexin.]
[J01DB03, cephalothin, The excretion of Cephalexin can be decreased when combined with Cefalotin.]
[J01DB08, cephapirin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefapirin.]
[J01DB09, cephradine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefradine.]
[H02AB13, deflazacort, The metabolism of Cephalexin can be increased when combined with Deflazacort.]
[L01EL03, zanubrutinib, The metabolism of Zanubrutinib can be decreased when combined with Cephalexin.]
[N03AX25, cenobamate, The serum concentration of Cephalexin can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Givosiran.]
[M09AX08, golodirsen, Cephalexin may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[S01XA12, dexpanthenol, Cephalexin may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[L01XX72, tazemetostat, The metabolism of Tazemetostat can be decreased when combined with Cephalexin.]
[J05AB16, remdesivir, The metabolism of Cephalexin can be decreased when combined with Remdesivir.]
[H02CA02, osilodrostat, The metabolism of Cephalexin can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Cephalexin can be decreased when combined with Amprenavir.]
[R02AA03, dichlorobenzyl alcohol, Cephalexin may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Cephalexin may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[M01AH02, rofecoxib, The risk or severity of nephrotoxicity can be increased when Rofecoxib is combined with Cephalexin.]
[L01XF03, bexarotene, The metabolism of Cephalexin can be increased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Cephalexin can be increased when combined with Clevidipine.]
[C01BD07, dronedarone, The metabolism of Dronedarone can be decreased when combined with Cephalexin.]
[J01FA13, dirithromycin, The metabolism of Cephalexin can be decreased when combined with Dirithromycin.]
[S03AA08, chloramphenicol, The metabolism of Cephalexin can be decreased when combined with Chloramphenicol.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Cephalexin.]
[L01EX17, capmatinib, The excretion of Cephalexin can be decreased when combined with Capmatinib.]
[D07XB03, fluprednidene, The metabolism of Cephalexin can be increased when combined with Fluprednidene.]
[M01AC04, droxicam, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Droxicam.]
[L01EX19, ripretinib, The excretion of Cephalexin can be decreased when combined with Ripretinib.]
[V08CA05, mangafodipir, Cephalexin may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The excretion of Cephalexin can be decreased when combined with Selpercatinib.]
[B01AE02, lepirudin, The therapeutic efficacy of Lepirudin can be decreased when used in combination with Cephalexin.]
[M02AA27, dexketoprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Dexketoprofen.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Dyclonine.]
[R06AX22, ebastine, The metabolism of Ebastine can be decreased when combined with Cephalexin.]
[M09AX10, risdiplam, The serum concentration of Cephalexin can be increased when it is combined with Risdiplam.]
[L04AC19, satralizumab, The serum concentration of Cephalexin can be decreased when it is combined with Satralizumab.]
[P01BA01, chloroquine, Cephalexin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EX23, pralsetinib, The metabolism of Cephalexin can be increased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AA01, chlorpromazine, The metabolism of Cephalexin can be increased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Cephalexin may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, Cephalexin may decrease the excretion rate of Chlorzoxazone which could result in a higher serum level.]
[N02BA07, ethenzamide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Ethenzamide.]
[M01AB08, etodolac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Etodolac.]
[M02AA06, etofenamate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Etofenamate.]
[B06AC06, berotralstat, The metabolism of Cephalexin can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Cephalexin can be decreased when combined with Lonafarnib.]
[M01AX25, chondroitin sulfates, Cephalexin may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[J05AJ04, cabotegravir, The excretion of Cephalexin can be decreased when combined with Cabotegravir.]
[P03AX07, abametapir, The serum concentration of Cephalexin can be increased when it is combined with Abametapir.]
[V03AF12, trilaciclib, The excretion of Cephalexin can be decreased when combined with Trilaciclib.]
[N03AX10, felbamate, The metabolism of Cephalexin can be increased when combined with Felbamate.]
[M01AE05, fenbufen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Fenbufen.]
[C01CA19, fenoldopam, Cephalexin may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[B03AB02, iron sucrose, The therapeutic efficacy of Cephalexin can be decreased when used in combination with Iron sucrose.]
[J01DD15, cefdinir, The excretion of Cefdinir can be decreased when combined with Cephalexin.]
[R03BA03, flunisolide, The metabolism of Cephalexin can be increased when combined with Flunisolide.]
[S02BA08, fluocinolone acetonide, The metabolism of Cephalexin can be increased when combined with Fluocinolone acetonide.]
[S01JA01, fluorescein, The excretion of Fluorescein can be decreased when combined with Cephalexin.]
[N02BG07, flupirtine, Cephalexin may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[A02BA01, cimetidine, The excretion of Cephalexin can be decreased when combined with Cimetidine.]
[V08CA04, gadoteridol, Cephalexin may decrease the excretion rate of Gadoteridol which could result in a higher serum level.]
[J01MB06, cinoxacin, The excretion of Cephalexin can be decreased when combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Cephalexin can be decreased when it is combined with Sotorasib.]
[L01EN03, infigratinib, The metabolism of Infigratinib can be decreased when combined with Cephalexin.]
[S03AA07, ciprofloxacin, The metabolism of Cephalexin can be decreased when combined with Ciprofloxacin.]
[L01XA01, cisplatin, Cephalexin may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The metabolism of Cephalexin can be decreased when combined with Citalopram.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The excretion of Cephalexin can be decreased when combined with Fexinidazole.]
[L04AA59, avacopan, The metabolism of Cephalexin can be decreased when combined with Avacopan.]
[M01AG01, mefenamic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Mefenamic acid.]
[N06AX25, St. John's wort extract, The metabolism of Cephalexin can be increased when combined with St. John's Wort.]
[L01EA06, asciminib, The metabolism of Cephalexin can be decreased when combined with Asciminib.]
[J04BA01, clofazimine, The metabolism of Cephalexin can be decreased when combined with Clofazimine.]
[B01AD11, tenecteplase, The therapeutic efficacy of Tenecteplase can be decreased when used in combination with Cephalexin.]
[C10AB01, clofibrate, The metabolism of Cephalexin can be increased when combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Cephalexin can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The metabolism of Cephalexin can be decreased when combined with Pacritinib.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Cephalexin.]
[N03AE01, clonazepam, Cephalexin may decrease the excretion rate of Clonazepam which could result in a higher serum level.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Cephalexin.]
[C01EB24, mavacamten, The serum concentration of Cephalexin can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, The excretion of Oseltamivir can be decreased when combined with Cephalexin.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AH02, clozapine, The metabolism of Cephalexin can be decreased when combined with Clozapine.]
[J01GB12, arbekacin, Cephalexin may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Cephalexin can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Cephalexin can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Proquazone.]
[R05DA04, codeine, The excretion of Cephalexin can be decreased when combined with Codeine.]
[M04AC01, colchicine, Cephalexin may decrease the excretion rate of Colchicine which could result in a higher serum level.]
[J01XB01, colistin, Cephalexin may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefpirome.]
[A04AA03, tropisetron, Cephalexin may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[A10BX03, nateglinide, Cephalexin may decrease the excretion rate of Nateglinide which could result in a higher serum level.]
[N02BA16, imidazole-2-hydroxybenzoate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Imidazole salicylate.]
[J01FA15, telithromycin, The metabolism of Cephalexin can be decreased when combined with Telithromycin.]
[B01AC10, indobufen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Indobufen.]
[J05AB14, valganciclovir, Cephalexin may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[J05AF09, emtricitabine, The excretion of Emtricitabine can be decreased when combined with Cephalexin.]
[C05BB03, invert sugar, Cephalexin may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Cephalexin may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Cephalexin may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Cephalexin may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Cephalexin may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Valdecoxib.]
[N02CC05, almotriptan, Cephalexin may decrease the excretion rate of Almotriptan which could result in a higher serum level.]
[M01AH04, parecoxib, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Parecoxib.]
[J02AC02, itraconazole, The metabolism of Cephalexin can be decreased when combined with Itraconazole.]
[B01AB12, bemiparin, The therapeutic efficacy of Bemiparin can be decreased when used in combination with Cephalexin.]
[S01AD03, acyclovir, The excretion of Acyclovir can be decreased when combined with Cephalexin.]
[N05BA10, ketazolam, The metabolism of Cephalexin can be decreased when combined with Ketazolam.]
[M01AA06, kebuzone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Kebuzone.]
[L01EA01, imatinib, The metabolism of Cephalexin can be decreased when combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Cephalexin can be decreased when combined with Posaconazole.]
[A02BC05, esomeprazole, The excretion of Cephalexin can be decreased when combined with Esomeprazole.]
[N03AX09, lamotrigine, Cephalexin may decrease the excretion rate of Lamotrigine which could result in a higher serum level.]
[S01BA03, cortisone, The metabolism of Cephalexin can be increased when combined with Cortisone.]
[N07BC04, lofexidine, Cephalexin may decrease the excretion rate of Lofexidine which could result in a higher serum level.]
[M01AB09, lonazolac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Lonazolac.]
[M02AA31, loxoprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Loxoprofen.]
[J01DC08, loracarbef, The risk or severity of nephrotoxicity can be increased when Loracarbef is combined with Cephalexin.]
[C09AA03, lisinopril, Cephalexin may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A06AD01, magnesium carbonate, Cephalexin may decrease the excretion rate of Magnesium carbonate which could result in a higher serum level.]
[C08CA11, manidipine, The metabolism of Cephalexin can be decreased when combined with Manidipine.]
[H02AB15, meprednisone, The metabolism of Cephalexin can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Cephalexin can be decreased when combined with Mequitazine.]
[J01DH02, meropenem, Cephalexin may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, Cephalexin may decrease the excretion rate of Melperone which could result in a higher serum level.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[J01FA03, midecamycin, The metabolism of Cephalexin can be decreased when combined with Midecamycin.]
[J05AF07, tenofovir disoproxil, Cephalexin may increase the nephrotoxic activities of Tenofovir disoproxil.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Cephalexin.]
[S01XA18, cyclosporine, The metabolism of Cyclosporine can be decreased when combined with Cephalexin.]
[N06BA07, modafinil, The metabolism of Cephalexin can be increased when combined with Modafinil.]
[C10AA07, rosuvastatin, The excretion of Rosuvastatin can be decreased when combined with Cephalexin.]
[M02AA02, mofebutazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Mofebutazone.]
[M01AX22, morniflumate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Morniflumate.]
[C03XA02, conivaptan, The metabolism of Cephalexin can be decreased when combined with Conivaptan.]
[M01AH05, etoricoxib, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Etoricoxib.]
[L01AX04, dacarbazine, Cephalexin may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Cephalexin can be decreased when combined with Danazol.]
[L01DB02, daunorubicin, The metabolism of Cephalexin can be decreased when combined with Daunorubicin.]
[M01AX01, nabumetone, The risk or severity of nephrotoxicity can be increased when Nabumetone is combined with Cephalexin.]
[N07BB05, nalmefene, Cephalexin may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[S01GX04, nedocromil, Cephalexin may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Cephalexin can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Cephalexin may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, Cephalexin may decrease the excretion rate of Nilutamide which could result in a higher serum level.]
[M03AC11, cisatracurium, Cephalexin may increase the neuromuscular blocking activities of Cisatracurium.]
[B01AX05, fondaparinux, Cephalexin may decrease the excretion rate of Fondaparinux which could result in a higher serum level.]
[A07EC03, olsalazine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Olsalazine.]
[N06AA01, desipramine, The metabolism of Cephalexin can be decreased when combined with Desipramine.]
[H01BA02, desmopressin, Cephalexin may decrease the excretion rate of Desmopressin which could result in a higher serum level.]
[V04CH02, indigo carmine, Cephalexin may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[J01DH03, ertapenem, Cephalexin may decrease the excretion rate of Ertapenem which could result in a higher serum level.]
[M01AE12, oxaprozin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Oxaprozin.]
[N03AF02, oxcarbazepine, The metabolism of Cephalexin can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Cephalexin can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Cephalexin can be decreased when combined with Oxybutynin.]
[L04AB04, adalimumab, The metabolism of Cephalexin can be increased when combined with Adalimumab.]
[N06BA02, dextroamphetamine, Cephalexin may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[C01DA05, pentaerythritol tetranitrate, Cephalexin may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Cephalexin may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, Cephalexin may decrease the excretion rate of Diazepam which could result in a higher serum level.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Phenol.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Cinchocaine.]
[R05DA08, pholcodine, Cephalexin may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[M05BA02, clodronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Clodronic acid.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The excretion of Cephalexin can be decreased when combined with Diclofenac.]
[J01CF01, dicloxacillin, The metabolism of Cephalexin can be increased when combined with Dicloxacillin.]
[J05AD01, foscarnet, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Foscarnet.]
[A03AA07, dicyclomine, Cephalexin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF03, zalcitabine, The excretion of Zalcitabine can be decreased when combined with Cephalexin.]
[J05AF02, didanosine, Cephalexin may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[L01DC04, ixabepilone, The metabolism of Ixabepilone can be decreased when combined with Cephalexin.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Cephalexin.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[L02AA01, diethylstilbestrol, The metabolism of Cephalexin can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Cephalexin can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Cephalexin can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Diflunisal.]
[C01AA04, digitoxin, The metabolism of Digitoxin can be decreased when combined with Cephalexin.]
[C01AA05, digoxin, Cephalexin may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[C04AE04, dihydroergocristine, The metabolism of Dihydroergocristine can be decreased when combined with Cephalexin.]
[N02CA01, dihydroergotamine, The metabolism of Dihydroergotamine can be decreased when combined with Cephalexin.]
[N02AA03, hydromorphone, Cephalexin may decrease the excretion rate of Hydromorphone which could result in a higher serum level.]
[L04AX04, lenalidomide, Cephalexin may decrease the excretion rate of Lenalidomide which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Cephalexin can be decreased when combined with Atazanavir.]
[H03BC01, potassium perchlorate, Cephalexin may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Cephalexin may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Cephalexin can be decreased when combined with Diltiazem.]
[V03AB09, dimercaprol, Cephalexin may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, The metabolism of Cephalexin can be decreased when combined with Dimethyl sulfoxide.]
[N02BB04, propyphenazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Propyphenazone.]
[M01AB14, proglumetacin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Proglumetacin.]
[G02AD02, dinoprostone, The excretion of Dinoprostone can be decreased when combined with Cephalexin.]
[C05CA03, diosmin, The metabolism of Cephalexin can be decreased when combined with Diosmin.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Proparacaine.]
[R06AA02, diphenhydramine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Diphenhydramine.]
[C09AA06, quinapril, The excretion of Quinapril can be decreased when combined with Cephalexin.]
[B01AC07, dipyridamole, The therapeutic efficacy of Dipyridamole can be decreased when used in combination with Cephalexin.]
[B01AD10, drotrecogin alfa, The therapeutic efficacy of Drotrecogin alfa can be decreased when used in combination with Cephalexin.]
[A03FA02, cisapride, The metabolism of Cisapride can be decreased when combined with Cephalexin.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Cephalexin.]
[S01AX06, resorcinol, Cephalexin may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, Cephalexin may decrease the excretion rate of Disopyramide which could result in a higher serum level.]
[P03AA04, disulfiram, The risk or severity of adverse effects can be increased when Cephalexin is combined with Disulfiram.]
[S02AA12, rifamycin SV, The metabolism of Cephalexin can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Cephalexin can be increased when combined with Rifapentine.]
[R06AE09, levocetirizine, Cephalexin may decrease the excretion rate of Levocetirizine which could result in a higher serum level.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Ropivacaine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Cephalexin.]
[A04AD12, aprepitant, The metabolism of Cephalexin can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, The metabolism of Tolvaptan can be decreased when combined with Cephalexin.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Cephalexin.]
[J05AE07, fosamprenavir, The metabolism of Cephalexin can be decreased when combined with Fosamprenavir.]
[G04BE08, tadalafil, Cephalexin may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, The risk or severity of nephrotoxicity can be increased when Ketorolac is combined with Cephalexin.]
[C01EB18, ranolazine, Cephalexin may decrease the excretion rate of Ranolazine which could result in a higher serum level.]
[N02BA06, salsalate, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Salsalate.]
[H05BA01, salmon calcitonin, Cephalexin may decrease the excretion rate of Salmon calcitonin which could result in a higher serum level.]
[C01CA07, dobutamine, Cephalexin may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[C01CA04, dopamine, Cephalexin may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA12, doxepin, Cephalexin may decrease the excretion rate of Doxepin which could result in a higher serum level.]
[L01DB01, doxorubicin, The metabolism of Doxorubicin can be decreased when combined with Cephalexin.]
[J01AA02, doxycycline, Cephalexin may decrease the excretion rate of Doxycycline which could result in a higher serum level.]
[A08AA10, sibutramine, Cephalexin may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[A12CA02, sodium sulfate, Cephalexin may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Cephalexin may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N02CC01, sumatriptan, Cephalexin may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Cephalexin may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[H01AA01, corticotropin, The metabolism of Cephalexin can be increased when combined with Corticotropin.]
[J01CG02, tazobactam, The excretion of Tazobactam can be decreased when combined with Cephalexin.]
[L01AX03, temozolomide, Cephalexin may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, The excretion of Cephalexin can be decreased when combined with Tenoxicam.]
[D01BA02, terbinafine, The metabolism of Cephalexin can be increased when combined with Terbinafine.]
[N06AX14, tianeptine, The metabolism of Tianeptine can be decreased when combined with Cephalexin.]
[C09AA02, enalapril, The excretion of Cephalexin can be decreased when combined with Enalapril.]
[M01AG02, tolfenamic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Tolfenamic acid.]
[N06AG03, toloxatone, Cephalexin may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, Cephalexin may decrease the excretion rate of Atomoxetine which could result in a higher serum level.]
[N03AX11, topiramate, The metabolism of Cephalexin can be increased when combined with Topiramate.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CC01, chloral hydrate, Cephalexin may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[B01AC18, triflusal, The therapeutic efficacy of Triflusal can be decreased when used in combination with Cephalexin.]
[C05CA04, troxerutin, The therapeutic efficacy of Troxerutin can be decreased when used in combination with Cephalexin.]
[L01CA04, vinorelbine, The metabolism of Vinorelbine can be decreased when combined with Cephalexin.]
[N06AX16, venlafaxine, Cephalexin may decrease the excretion rate of Venlafaxine which could result in a higher serum level.]
[C08CA12, mepirodipine, The metabolism of Cephalexin can be decreased when combined with Barnidipine.]
[S01EA01, epinephrine, The metabolism of Cephalexin can be decreased when combined with Epinephrine.]
[B05XA12, zinc chloride, Zinc chloride can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B05XA18, zinc sulfate, Zinc sulfate can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M01AB04, zomepirac, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Zomepirac.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AD03, anistreplase, The therapeutic efficacy of Anistreplase can be decreased when used in combination with Cephalexin.]
[L01XA02, carboplatin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Carboplatin.]
[C02AC02, guanfacine, Cephalexin may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[N02CA02, ergotamine, The metabolism of Cephalexin can be decreased when combined with Ergotamine.]
[L03AX05, pidotimod, Cephalexin may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The metabolism of Cephalexin can be decreased when combined with Erythromycin.]
[N05CD04, estazolam, Cephalexin may decrease the excretion rate of Estazolam which could result in a higher serum level.]
[A02BC02, pantoprazole, The excretion of Cephalexin can be decreased when combined with Pantoprazole.]
[G03CA03, estradiol, The excretion of Estradiol can be decreased when combined with Cephalexin.]
[G03CA57, estrogens, conjugated (USP), The excretion of Cephalexin can be decreased when combined with Conjugated estrogens.]
[J04AK02, ethambutol, Cephalexin may decrease the excretion rate of Ethambutol which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Cephalexin can be increased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Cephalexin can be increased when combined with Fluticasone.]
[V08CA03, gadodiamide, Cephalexin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.]
[C01BD05, ibutilide, Cephalexin may decrease the excretion rate of Ibutilide which could result in a higher serum level.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Meloxicam.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Etidocaine.]
[N01AX07, etomidate, Cephalexin may decrease the excretion rate of Etomidate which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Cephalexin.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Cephalexin.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Cephalexin.]
[R06AX12, terfenadine, The metabolism of Cephalexin can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Cephalexin may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, Cephalexin may decrease the excretion rate of Bupropion which could result in a higher serum level.]
[N06AB08, fluvoxamine, The metabolism of Cephalexin can be decreased when combined with Fluvoxamine.]
[L02AE02, leuprolide, Cephalexin may decrease the excretion rate of Leuprolide which could result in a higher serum level.]
[C10AA03, pravastatin, The excretion of Cephalexin can be decreased when combined with Pravastatin.]
[M01CB01, gold sodium thiomalate, Cephalexin may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Cephalexin may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Cephalexin may decrease the excretion rate of Dexrazoxane which could result in a higher serum level.]
[A02BA03, famotidine, The excretion of Famotidine can be decreased when combined with Cephalexin.]
[A16AA01, levocarnitine, The excretion of Levocarnitine can be decreased when combined with Cephalexin.]
[P02CA03, albendazole, The metabolism of Cephalexin can be decreased when combined with Albendazole.]
[M01AE04, fenoprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Fenoprofen.]
[N02AB03, fentanyl, Cephalexin may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, Cephalexin may decrease the excretion rate of Salbutamol which could result in a higher serum level.]
[B01AD05, plasmin, The therapeutic efficacy of Fibrinolysin can be decreased when used in combination with Cephalexin.]
[L01BB06, clofarabine, The excretion of Clofarabine can be decreased when combined with Cephalexin.]
[N07AX03, cevimeline, Cephalexin may decrease the excretion rate of Cevimeline which could result in a higher serum level.]
[G04BD02, flavoxate, Cephalexin may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The excretion of Flecainide can be decreased when combined with Cephalexin.]
[N02BG04, floctafenine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Floctafenine.]
[J01CF05, floxacillin, The metabolism of Cephalexin can be increased when combined with Flucloxacillin.]
[J02AC01, fluconazole, The metabolism of Cephalexin can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Cephalexin may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Cephalexin may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[D07AC08, fluocinonide, The metabolism of Cephalexin can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Cephalexin can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The metabolism of Cephalexin can be increased when combined with Ethanol.]
[L01BC09, floxuridine, Cephalexin may decrease the excretion rate of Floxuridine which could result in a higher serum level.]
[N06AB03, fluoxetine, The metabolism of Cephalexin can be decreased when combined with Fluoxetine.]
[N05CD01, flurazepam, Cephalexin may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Flurbiprofen.]
[L02BB01, flutamide, Cephalexin may decrease the excretion rate of Flutamide which could result in a higher serum level.]
[V04CX02, folic acid, Cephalexin may decrease the excretion rate of Folic acid which could result in a higher serum level.]
[S02AA17, fosfomycin, Cephalexin may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, The risk or severity of nephrotoxicity can be increased when Framycetin is combined with Cephalexin.]
[L01BC03, tegafur, Cephalexin may decrease the excretion rate of Tegafur which could result in a higher serum level.]
[J05AE10, darunavir, The metabolism of Cephalexin can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Furosemide may decrease the excretion rate of Cephalexin which could result in a higher serum level.]
[M05BA04, alendronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Alendronic acid.]
[N05CF04, eszopiclone, Cephalexin may decrease the excretion rate of Eszopiclone which could result in a higher serum level.]
[S01AD09, ganciclovir, The excretion of Cephalexin can be decreased when combined with Ganciclovir.]
[N03AA04, barbexaclone, The metabolism of Cephalexin can be increased when combined with Barbexaclone.]
[C10AB04, gemfibrozil, The excretion of Cephalexin can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, Cephalexin may decrease the excretion rate of Telavancin which could result in a higher serum level.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Cephalexin.]
[N04BC06, cabergoline, The metabolism of Cabergoline can be decreased when combined with Cephalexin.]
[J05AG04, etravirine, The metabolism of Cephalexin can be increased when combined with Etravirine.]
[L01EH01, lapatinib, The metabolism of Cephalexin can be decreased when combined with Lapatinib.]
[A10BB01, glyburide, The excretion of Cephalexin can be decreased when combined with Glyburide.]
[A10BB07, glipizide, Cephalexin may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, Cephalexin may decrease the excretion rate of Dexmedetomidine which could result in a higher serum level.]
[C01BD04, dofetilide, The metabolism of Dofetilide can be decreased when combined with Cephalexin.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Cephalexin.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Cephalexin.]
[M01CB04, aurothioglucose, Cephalexin may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Cephalexin may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[B01AA12, fluindione, The risk or severity of bleeding can be increased when Cephalexin is combined with Fluindione.]
[C09AA09, fosinopril, Cephalexin may decrease the excretion rate of Fosinopril which could result in a higher serum level.]
[D01BA01, griseofulvin, The metabolism of Cephalexin can be increased when combined with Griseofulvin.]
[S01EX01, guanethidine, Cephalexin may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, Cephalexin may decrease the excretion rate of Goserelin which could result in a higher serum level.]
[N05AD01, haloperidol, The serum concentration of Haloperidol can be increased when it is combined with Cephalexin.]
[N05AH04, quetiapine, Cephalexin may decrease the excretion rate of Quetiapine which could result in a higher serum level.]
[N06BX13, idebenone, Cephalexin may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Cephalexin.]
[M04AA01, allopurinol, The excretion of Allopurinol can be decreased when combined with Cephalexin.]
[C09CA01, losartan, The metabolism of Cephalexin can be decreased when combined with Losartan.]
[S01XA14, heparin, The therapeutic efficacy of Heparin can be decreased when used in combination with Cephalexin.]
[G03DC01, allylestrenol, The metabolism of Allylestrenol can be decreased when combined with Cephalexin.]
[A07EC02, mesalamine, The risk or severity of nephrotoxicity can be increased when Mesalazine is combined with Cephalexin.]
[C01CE02, milrinone, Cephalexin may decrease the excretion rate of Milrinone which could result in a higher serum level.]
[C08CA10, nilvadipine, The metabolism of Cephalexin can be decreased when combined with Nilvadipine.]
[M02AA26, nimesulide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Nimesulide.]
[C09AA04, perindopril, Cephalexin may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, The metabolism of Cephalexin can be decreased when combined with Hydralazine.]
[C03AA03, hydrochlorothiazide, The excretion of Hydrochlorothiazide can be decreased when combined with Cephalexin.]
[S02BA01, hydrocortisone, The excretion of Hydrocortisone can be decreased when combined with Cephalexin.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Cephalexin may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Cephalexin may decrease the excretion rate of Hydroxocobalamin which could result in a higher serum level.]
[G04BD06, propiverine, Cephalexin may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[B05AA07, hetastarch, Cephalexin may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[J04AB04, rifabutin, The metabolism of Cephalexin can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Risedronic acid.]
[R02AX02, ibuprofen, The excretion of Cephalexin can be decreased when combined with Ibuprofen.]
[B05XA08, sodium acetate, Cephalexin may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[B05CB02, sodium citrate, The therapeutic efficacy of Sodium citrate can be decreased when used in combination with Cephalexin.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Cephalexin.]
[N06AA02, imipramine, Cephalexin may decrease the excretion rate of Imipramine which could result in a higher serum level.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Cephalexin.]
[R01AD07, tixocortol, Cephalexin may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[L01CE01, topotecan, The excretion of Topotecan can be decreased when combined with Cephalexin.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, The excretion of Cephalexin can be decreased when combined with Indomethacin.]
[A16AX05, zinc acetate, Zinc acetate can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CB02, zinc gluconate, Zinc gluconate can cause a decrease in the absorption of Cephalexin resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A11HA07, inositol, Cephalexin may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Cephalexin can be decreased when combined with Milnacipran.]
[S01XA28, varenicline, Cephalexin may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Articaine.]
[A10BH01, sitagliptin, The excretion of Sitagliptin can be decreased when combined with Cephalexin.]
[N05BA12, alprazolam, Cephalexin may decrease the excretion rate of Alprazolam which could result in a higher serum level.]
[N05CH02, ramelteon, Cephalexin may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[C10AA06, cerivastatin, The metabolism of Cephalexin can be increased when combined with Cerivastatin.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, Cephalexin may decrease the excretion rate of Ipecac which could result in a higher serum level.]
[J05AF04, stavudine, The excretion of Stavudine can be decreased when combined with Cephalexin.]
[G04BE01, alprostadil, The excretion of Alprostadil can be decreased when combined with Cephalexin.]
[J04AC01, isoniazid, The metabolism of Cephalexin can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Cephalexin may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, Cephalexin may decrease the excretion rate of Isosorbide mononitrate which could result in a higher serum level.]
[D10BA01, isotretinoin, Cephalexin may decrease the excretion rate of Isotretinoin which could result in a higher serum level.]
[B01AE06, bivalirudin, The therapeutic efficacy of Bivalirudin can be decreased when used in combination with Cephalexin.]
[S01AA24, kanamycin, Cephalexin may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[L04AC07, tocilizumab, The metabolism of Cephalexin can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, Cephalexin may decrease the excretion rate of Ketamine which could result in a higher serum level.]
[B01AC22, prasugrel, Cephalexin may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[H02CA04, levoketoconazole, The metabolism of Cephalexin can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Cephalexin can be decreased when combined with Ketoconazole.]
[M02AA10, ketoprofen, The excretion of Cephalexin can be decreased when combined with Ketoprofen.]
[V03AC03, deferasirox, The metabolism of Cephalexin can be increased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Cephalexin can be increased when combined with Abatacept.]
[J01MB02, nalidixic acid, The excretion of Cephalexin can be decreased when combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Tiaprofenic acid.]
[C07AG01, labetalol, Cephalexin may decrease the excretion rate of Labetalol which could result in a higher serum level.]
[N04BB01, amantadine, Cephalexin may decrease the excretion rate of Amantadine which could result in a higher serum level.]
[A06AD11, lactulose, The therapeutic efficacy of Lactulose can be decreased when used in combination with Cephalexin.]
[A06AX03, lubiprostone, Cephalexin may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The metabolism of Lacosamide can be decreased when combined with Cephalexin.]
[C03CC01, ethacrynic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Etacrynic acid.]
[S02DA01, lidocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Lidocaine.]
[S01AA21, amikacin, Cephalexin may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Cephalexin can be increased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05BA06, lorazepam, Cephalexin may decrease the excretion rate of Lorazepam which could result in a higher serum level.]
[C10AA02, lovastatin, The metabolism of Cephalexin can be decreased when combined with Lovastatin.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Cephalexin.]
[B05XA11, magnesium chloride, Cephalexin may decrease the excretion rate of Magnesium chloride which could result in a higher serum level.]
[G04BX01, magnesium hydroxide, Cephalexin may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.]
[L01BA05, pralatrexate, Cephalexin may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Cephalexin can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, The risk or severity of nephrotoxicity can be increased when Mannitol is combined with Cephalexin.]
[N06AA21, maprotiline, Cephalexin may decrease the excretion rate of Maprotiline which could result in a higher serum level.]
[C02BB01, mecamylamine, Cephalexin may decrease the excretion rate of Mecamylamine which could result in a higher serum level.]
[M02AA18, meclofenamic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Meclofenamic acid.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[B01AB06, nadroparin, The therapeutic efficacy of Nadroparin can be decreased when used in combination with Cephalexin.]
[B01AB05, enoxaparin, The therapeutic efficacy of Enoxaparin can be decreased when used in combination with Cephalexin.]
[B01AB04, dalteparin, The therapeutic efficacy of Dalteparin can be decreased when used in combination with Cephalexin.]
[N05CH01, melatonin, The excretion of Cephalexin can be decreased when combined with Melatonin.]
[N06DX01, memantine, Cephalexin may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, The metabolism of Cephalexin can be decreased when combined with Meperidine.]
[N03AA01, mephobarbital, The metabolism of Cephalexin can be increased when combined with Methylphenobarbital.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Mepivacaine.]
[G04BX16, tiopronin, Cephalexin may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[L02BG01, aminoglutethimide, The metabolism of Cephalexin can be increased when combined with Aminoglutethimide.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AX13, paliperidone, Cephalexin may decrease the excretion rate of Paliperidone which could result in a higher serum level.]
[A10BA02, metformin, Cephalexin may decrease the excretion rate of Metformin which could result in a higher serum level.]
[H01CB03, lanreotide, The metabolism of Cephalexin can be decreased when combined with Lanreotide.]
[N07BC02, methadone, The metabolism of Cephalexin can be decreased when combined with Methadone.]
[N06BA03, methamphetamine, Cephalexin may decrease the excretion rate of Metamfetamine which could result in a higher serum level.]
[J05AF05, lamivudine, Cephalexin may decrease the excretion rate of Lamivudine which could result in a higher serum level.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Cephalexin can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Cephalexin may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[A11HA02, pyridoxine, Cephalexin may decrease the excretion rate of Pyridoxine which could result in a higher serum level.]
[L04AX03, methotrexate, The metabolism of Methotrexate can be decreased when combined with Cephalexin.]
[D05BA02, methoxsalen, Cephalexin may decrease the excretion rate of Methoxsalen which could result in a higher serum level.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, Cephalexin may decrease the excretion rate of Methyldopa which could result in a higher serum level.]
[V04CG05, methylene blue, The metabolism of Cephalexin can be decreased when combined with Methylene blue.]
[G02AB01, methylergonovine, The metabolism of Cephalexin can be decreased when combined with Methylergometrine.]
[R03DA05, aminophylline, The metabolism of Aminophylline can be decreased when combined with Cephalexin.]
[H02AB04, methylprednisolone, The metabolism of Cephalexin can be increased when combined with Methylprednisolone.]
[N03AF03, rufinamide, The metabolism of Cephalexin can be increased when combined with Rufinamide.]
[G03EK01, methyltestosterone, The excretion of Cephalexin can be increased when combined with Methyltestosterone.]
[N02CA04, methysergide, The metabolism of Cephalexin can be decreased when combined with Methysergide.]
[A03FA01, metoclopramide, Cephalexin may decrease the excretion rate of Metoclopramide which could result in a higher serum level.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, Cephalexin may decrease the excretion rate of Metoprolol which could result in a higher serum level.]
[P01AB01, metronidazole, The metabolism of Cephalexin can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, The metabolism of Cephalexin can be increased when combined with Metyrapone.]
[S02AA13, miconazole, The metabolism of Cephalexin can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Aminophenazone.]
[B01AB07, parnaparin, The therapeutic efficacy of Parnaparin can be decreased when used in combination with Cephalexin.]
[N05CD08, midazolam, The metabolism of Cephalexin can be decreased when combined with Midazolam.]
[G03XB01, mifepristone, The metabolism of Cephalexin can be increased when combined with Mifepristone.]
[B01AB10, tinzaparin, The therapeutic efficacy of Tinzaparin can be decreased when used in combination with Cephalexin.]
[J05AH01, zanamivir, Cephalexin may decrease the excretion rate of Zanamivir which could result in a higher serum level.]
[J01AA08, minocycline, The excretion of Cephalexin can be decreased when combined with Minocycline.]
[J01FA11, miocamycin, The metabolism of Cephalexin can be decreased when combined with Miocamycin.]
[L01XX23, mitotane, The metabolism of Cephalexin can be increased when combined with Mitotane.]
[L03AC01, aldesleukin, The metabolism of Cephalexin can be decreased when combined with Aldesleukin.]
[C01BD01, amiodarone, The metabolism of Cephalexin can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, Cephalexin may decrease the excretion rate of Amitriptyline which could result in a higher serum level.]
[A04AA05, palonosetron, Cephalexin may decrease the excretion rate of Palonosetron which could result in a higher serum level.]
[J01DD06, moxalactam, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Latamoxef.]
[L04AB05, certolizumab pegol, The metabolism of Cephalexin can be increased when combined with Certolizumab pegol.]
[G04BA01, ammonium chloride, Cephalexin may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Cephalexin.]
[L04AA06, mycophenolic acid, Cephalexin may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[N05CA02, amobarbital, The metabolism of Cephalexin can be increased when combined with Amobarbital.]
[G03XC01, raloxifene, The metabolism of Cephalexin can be decreased when combined with Raloxifene.]
[N03AB05, fosphenytoin, The metabolism of Cephalexin can be increased when combined with Fosphenytoin.]
[C07AA12, nadolol, Cephalexin may decrease the excretion rate of Nadolol which could result in a higher serum level.]
[J01CA04, amoxicillin, Cephalexin may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[J01CF06, nafcillin, The metabolism of Cephalexin can be increased when combined with Nafcillin.]
[V03AB15, naloxone, The metabolism of Cephalexin can be decreased when combined with Naloxone.]
[L04AC03, anakinra, The metabolism of Cephalexin can be increased when combined with Anakinra.]
[N06BA01, amphetamine, Cephalexin may decrease the excretion rate of Amphetamine which could result in a higher serum level.]
[M02AA12, naproxen, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Naproxen.]
[A10BG01, troglitazone, The metabolism of Cephalexin can be increased when combined with Troglitazone.]
[N06AX21, duloxetine, Cephalexin may decrease the excretion rate of Duloxetine which could result in a higher serum level.]
[N04BX01, tolcapone, Cephalexin may decrease the excretion rate of Tolcapone which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Cephalexin.]
[S03AA01, neomycin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Neomycin.]
[B01AC17, tirofiban, Cephalexin may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[J02AA01, amphotericin B, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Amphotericin B.]
[S01AA19, ampicillin, Cephalexin may decrease the excretion rate of Ampicillin which could result in a higher serum level.]
[L03AX16, plerixafor, Cephalexin may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Cephalexin may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Cephalexin can be decreased when combined with Desvenlafaxine.]
[J05AB11, valacyclovir, The excretion of Valaciclovir can be decreased when combined with Cephalexin.]
[C01CE01, inamrinone, Cephalexin may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The metabolism of Cephalexin can be decreased when combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Cephalexin can be decreased when combined with Nicardipine.]
[C08CA05, nifedipine, Cephalexin may decrease the excretion rate of Nifedipine which could result in a higher serum level.]
[M02AA17, niflumic acid, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Niflumic acid.]
[C08CA07, nisoldipine, Cephalexin may decrease the excretion rate of Nisoldipine which could result in a higher serum level.]
[R07AX01, nitric oxide, Cephalexin may decrease the excretion rate of Nitric Oxide which could result in a higher serum level.]
[J01XE01, nitrofurantoin, Cephalexin may decrease the excretion rate of Nitrofurantoin which could result in a higher serum level.]
[N05CF03, zaleplon, Cephalexin may decrease the excretion rate of Zaleplon which could result in a higher serum level.]
[N04BC05, pramipexole, Cephalexin may decrease the excretion rate of Pramipexole which could result in a higher serum level.]
[C02DD01, nitroprusside, Cephalexin may decrease the excretion rate of Nitroprusside which could result in a higher serum level.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Cephalexin.]
[S01AE02, norfloxacin, The excretion of Cephalexin can be decreased when combined with Norfloxacin.]
[C02KX01, bosentan, The metabolism of Cephalexin can be increased when combined with Bosentan.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Cephalexin.]
[R05DA07, noscapine, The metabolism of Cephalexin can be decreased when combined with Noscapine.]
[B01AB08, reviparin, The therapeutic efficacy of Reviparin can be decreased when used in combination with Cephalexin.]
[H01CB02, octreotide, The metabolism of Cephalexin can be decreased when combined with Octreotide.]
[S02AA16, ofloxacin, The excretion of Cephalexin can be decreased when combined with Ofloxacin.]
[J01FA05, oleandomycin, The metabolism of Cephalexin can be decreased when combined with Oleandomycin.]
[L04AC04, rilonacept, The metabolism of Cephalexin can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Cephalexin can be increased when combined with Omeprazole.]
[N02AA02, opium, Cephalexin may decrease the excretion rate of Opium which could result in a higher serum level.]
[B01AD07, reteplase, The therapeutic efficacy of Reteplase can be decreased when used in combination with Cephalexin.]
[B01AD09, ancrod, The therapeutic efficacy of Ancrod can be decreased when used in combination with Cephalexin.]
[G04CA02, tamsulosin, Cephalexin may decrease the excretion rate of Tamsulosin which could result in a higher serum level.]
[C01AC01, ouabain, The excretion of Cephalexin can be decreased when combined with Ouabain.]
[M05BA08, zoledronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Zoledronic acid.]
[J01CF04, oxacillin, Cephalexin may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[N05BA04, oxazepam, Cephalexin may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[S01BC02, oxyphenbutazone, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Oxyphenbutazone.]
[S01AA04, oxytetracycline, The excretion of Oxytetracycline can be decreased when combined with Cephalexin.]
[V04CH30, 4-aminohippuric acid, The excretion of Cephalexin can be decreased when combined with Aminohippuric acid.]
[B01AB09, danaparoid, The therapeutic efficacy of Danaparoid can be decreased when used in combination with Cephalexin.]
[J04AB30, capreomycin, Cephalexin may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[H02AB05, paramethasone, The metabolism of Cephalexin can be increased when combined with Paramethasone.]
[A07AA06, paromomycin, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Paromomycin.]
[G04BD11, fesoterodine, Cephalexin may decrease the excretion rate of Fesoterodine which could result in a higher serum level.]
[C07AA23, penbutolol, Cephalexin may decrease the excretion rate of Penbutolol which could result in a higher serum level.]
[S01AA14, penicillin G, The excretion of Benzylpenicillin can be decreased when combined with Cephalexin.]
[J01CE09, penicillin G procaine, Cephalexin may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Cephalexin can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Cephalexin may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Cephalexin may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N02BE03, phenacetin, The excretion of Cephalexin can be decreased when combined with Phenacetin.]
[G04BX06, phenazopyridine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Phenazopyridine.]
[N06AF03, phenelzine, Cephalexin may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[B01AA02, phenindione, The risk or severity of bleeding can be increased when Cephalexin is combined with Phenindione.]
[N03AA02, phenobarbital, The metabolism of Cephalexin can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Cephalexin.]
[V03AB36, phentolamine, Cephalexin may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, The excretion of Cephalexin can be decreased when combined with Phenylbutazone.]
[N03AB02, phenytoin, The metabolism of Cephalexin can be increased when combined with Phenytoin.]
[L04AB06, golimumab, The metabolism of Cephalexin can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, Cephalexin may decrease the excretion rate of Levofloxacin which could result in a higher serum level.]
[N07BB03, acamprosate, The excretion of Acamprosate can be decreased when combined with Cephalexin.]
[L02BB03, bicalutamide, The metabolism of Bicalutamide can be decreased when combined with Cephalexin.]
[B02BA01, vitamin K1, Cephalexin may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, The risk or severity of nephrotoxicity can be increased when Cidofovir is combined with Cephalexin.]
[C08CX01, mibefradil, The metabolism of Cephalexin can be decreased when combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Cephalexin.]
[C07AA03, pindolol, Cephalexin may decrease the excretion rate of Pindolol which could result in a higher serum level.]
[J01CA12, piperacillin, The excretion of Piperacillin can be decreased when combined with Cephalexin.]
[J05AE01, saquinavir, The metabolism of Cephalexin can be decreased when combined with Saquinavir.]
[N06BX03, piracetam, Cephalexin may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[S01BC06, piroxicam, The excretion of Cephalexin can be decreased when combined with Piroxicam.]
[J01DD16, cefditoren, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Cefditoren.]
[J01MA11, grepafloxacin, The excretion of Grepafloxacin can be decreased when combined with Cephalexin.]
[J05AG02, delavirdine, The metabolism of Cephalexin can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Cephalexin can be decreased when combined with Irbesartan.]
[B01AC13, abciximab, The therapeutic efficacy of Abciximab can be decreased when used in combination with Cephalexin.]
[S01XA13, alteplase, The therapeutic efficacy of Alteplase can be decreased when used in combination with Cephalexin.]
[A10BG02, rosiglitazone, Cephalexin may decrease the excretion rate of Rosiglitazone which could result in a higher serum level.]
[L04AC08, canakinumab, The metabolism of Cephalexin can be increased when combined with Canakinumab.]
[S03AA03, polymyxin B, The risk or severity of adverse effects can be increased when Cephalexin is combined with Polymyxin B.]
[C03AA05, polythiazide, The excretion of Polythiazide can be decreased when combined with Cephalexin.]
[J05AE03, ritonavir, The serum concentration of Cephalexin can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, The excretion of Saxagliptin can be decreased when combined with Cephalexin.]
[B05XA01, potassium chloride, Cephalexin may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[S03BA02, prednisolone, The metabolism of Cephalexin can be increased when combined with Prednisolone.]
[H02AB07, prednisone, Cephalexin may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Cephalexin can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Cephalexin can be increased when combined with Primidone.]
[M04AB01, probenecid, The serum concentration of Cephalexin can be increased when it is combined with Probenecid.]
[C01BA02, procainamide, The excretion of Procainamide can be decreased when combined with Cephalexin.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Cephalexin is combined with Procaine.]
[C10AB05, fenofibrate, The metabolism of Fenofibrate can be decreased when combined with Cephalexin.]
[R06AD02, promethazine, Cephalexin may decrease the excretion rate of Promethazine which could result in a higher serum level.]
[A03AB05, propantheline, Cephalexin may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[R06AX26, fexofenadine, The excretion of Fexofenadine can be decreased when combined with Cephalexin.]
[L01XH02, romidepsin, The metabolism of Romidepsin can be decreased when combined with Cephalexin.]
[N01AX10, propofol, The metabolism of Cephalexin can be decreased when combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Cephalexin can be decreased when combined with Dextropropoxyphene.]
[C07AA05, propranolol, Cephalexin may decrease the excretion rate of Propranolol which could result in a higher serum level.]
[N02CC04, rizatriptan, Cephalexin may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Cephalexin may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[N07XX07, dalfampridine, Cephalexin may decrease the excretion rate of Dalfampridine which could result in a higher serum level.]
[P02CC01, pyrantel, Cephalexin may decrease the excretion rate of Pyrantel which could result in a higher serum level.]
[J04AK01, pyrazinamide, Cephalexin may decrease the excretion rate of Pyrazinamide which could result in a higher serum level.]
[P01BD01, pyrimethamine, The excretion of Cephalexin can be decreased when combined with Pyrimethamine.]
[C01BA01, quinidine, Cephalexin may decrease the excretion rate of Quinidine which could result in a higher serum level.]
[P01BC01, quinine, The metabolism of Cephalexin can be increased when combined with Quinine.]
[A02BA02, ranitidine, The excretion of Ranitidine can be decreased when combined with Cephalexin.]
[C02AA02, reserpine, Cephalexin may decrease the excretion rate of Reserpine which could result in a higher serum level.]
[J05AP01, ribavirin, Cephalexin may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[S01XA26, riboflavin, The excretion of Cephalexin can be decreased when combined with Riboflavin.]
[J04AB02, rifampin, The metabolism of Cephalexin can be increased when combined with Rifampicin.]
[J01FA06, roxithromycin, The metabolism of Cephalexin can be decreased when combined with Roxithromycin.]
[N02BA05, salicylamide, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Salicylamide.]
[A07EC01, sulfasalazine, The risk or severity of nephrotoxicity can be increased when Cephalexin is combined with Sulfasalazine.]
[S01BC08, salicylic acid, The excretion of Cephalexin can be decreased when combined with Salicylic acid.]
[N05CA06, secobarbital, The metabolism of Cephalexin can be increased when combined with Secobarbital.]
[J01GB08, sisomicin, Cephalexin may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Cephalexin may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[H01CB01, somatostatin, The metabolism of Cephalexin can be decreased when combined with Somatostatin.]
[V04CC01, sorbitol, Cephalexin may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Cephalexin.]
[C03DA01, spironolactone, Spironolactone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Cephalexin.]
[N02BA03, choline salicylate, Cephalexin may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Cephalexin may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Cephalexin may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Cephalexin may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[N03AG01, valproic acid, The excretion of Valproic acid can be decreased when combined with Cephalexin.]
[M05BA01, etidronic acid, The risk or severity of nephrotoxicity and hypocalcemia can be increased when Cephalexin is combined with Etidronic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Cephalexin can be increased when combined with Hydrocortisone butyrate.]
[D10AX03, azelaic acid, Cephalexin may decrease the excretion rate of Azelaic acid which could result in a higher serum level.]
